1 | C (migalastat) | [1] Migalastat Migalastat | [1] Migalastat
Migalastat
💬 | - | - | [1] 19 19 💬 |
2 | C-028380 | - | - | - | - | [1] 106 106 💬 |
3 | C-11 PiB | [1] Pittsburgh Compound B Pittsburgh Compound B | - | - | - | [1] 127 127 💬 |
4 | C-82 Topical Gel, 1% | - | - | - | - | [1] 51 51 💬 |
5 | C-kit+ cells | - | - | - | - | [1] 211 211 💬 |
6 | C-Trelin OD Tab(5mg Taltirelin Hydrate) | - | - | - | - | [1] 18 18 💬 |
7 | C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker | [1] Polyethylene glycol Polyethylene glycol | [1] Polyethylene glycol 3350
Polyethylene glycol 3350
💬 | - | - | [1] 276 276 💬 |
8 | C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER | [1] Polyethylene glycol Polyethylene glycol | [1] Polyethylene glycol 3350
Polyethylene glycol 3350
💬 | - | - | [1] 276 276 💬 |
9 | C. albicans | - | - | - | - | [1] 46 46 💬 |
10 | C01CA04 - Dopamina | [1] Dopamine Dopamine | [1] Dopamine
Dopamine
💬 | [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 299 299 💬 |
11 | C01EB18 | - | - | - | - | [1] 58 58 💬 |
12 | C03XA01 | - | - | - | - | [2] 67 67, 72 💬 |
13 | C07AB07 | - | - | - | - | [1] 86 86 💬 |
14 | C09 | - | - | - | - | [1] 66 66 💬 |
15 | C1 ESTERASE INHIBITOR (HUMAN) | - | - | - | - | [1] 65 65 💬 |
16 | C1 Esterase Inhibitor Human | - | - | - | - | [1] 65 65 💬 |
17 | C1 inhibitor | [1] Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | [1] 65 65 💬 |
18 | C1 inhibitor concentrate | [1] Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | [1] 65 65 💬 |
19 | C1-esterase inhibitor (Cinryze) | [1] Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | [1] 13 13 💬 |
20 | C1-esterase inhibitor [recombinant] (C1-INH-R) | [1] Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | [1] 65 65 💬 |
21 | C1-INH | [1] Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | [1] 65 65 💬 |
22 | C105 | - | - | - | - | [1] 13 13 💬 |
23 | C106 solution | - | - | - | - | [1] 85 85 💬 |
24 | C10AA05 | - | - | - | - | [1] 46 46 💬 |
25 | C10AB02 | - | - | - | - | [1] 94 94 💬 |
26 | C11-methionine | [1] Methionine Methionine | [1] Methionine
Methionine
💬 | - | - | [1] 84 84 💬 |
27 | C21 | - | - | - | - | [2] 51 51, 85 💬 |
28 | C225 | - | - | - | - | [2] 51 51, 86 💬 |
29 | C326, IL-6 Inhibitory Avimer protein | - | - | - | - | [1] 96 96 💬 |
30 | C5 inh MAb, SKY59, RO/CH7092230 | - | - | - | - | [2] 62 62, 109 💬 |
31 | C5 Inhibitor | - | - | - | - | [1] 62 62 💬 |
32 | CA | - | - | - | - | [1] 234 234 💬 |
33 | CA2 | - | - | - | - | [1] 271 271 💬 |
34 | Cabaletta | [1] Trehalose Trehalose | - | - | - | [2] 18 18, 113 💬 |
35 | Cabaletta for IV infusion once weekly during 24 weeks | [1] Trehalose Trehalose | - | - | - | [1] 18 18 💬 |
36 | Cabaser | - | - | - | - | [1] 6 6 💬 |
37 | Cabaseril | - | - | - | - | [1] 6 6 💬 |
38 | Cabaseril, 1,0 mg Tablette | - | - | - | - | [1] 6 6 💬 |
39 | Cabaseril, 2,0 mg Tablette | - | - | - | - | [1] 6 6 💬 |
40 | CABERGOLINA | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬 | [2] DRD2 DRD2, PRL 💬 | [12] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2] 6 6, 75 💬 |
41 | Cabergoline | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬 | [2] DRD2 DRD2, PRL 💬 | [12] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [3] 6 6, 74, 75 💬 |
42 | CABERGOLINE TEVA | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬 | [2] DRD2 DRD2, PRL 💬 | [12] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 75 75 💬 |
43 | CABLIVI | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬 | [1] VWF VWF 💬 | [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬 |
44 | Cablivi® | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬 | [1] VWF VWF 💬 | [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬 |
45 | Cabotegravir | [1] Cabotegravir Cabotegravir | [1] Cabotegravir
Cabotegravir
💬 | - | - | [1] 256 256 💬 |
46 | Cabotegravir (CAB) tablet | [1] Cabotegravir Cabotegravir | [1] Cabotegravir
Cabotegravir
💬 | - | - | [1] 256 256 💬 |
47 | Cabotegravir - Injectable Suspension (CAB LA) | [1] Cabotegravir Cabotegravir | [1] Cabotegravir
Cabotegravir
💬 | - | - | [1] 256 256 💬 |
48 | Cabozantinib | [1] Cabozantinib Cabozantinib | [1] Cabozantinib
Cabozantinib
💬 | [3] AXL AXL, KDR, MET 💬 | [25] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, EGFR tyrosine kinase inhibitor resistance, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 34 34 💬 |
49 | CAEL-101 | - | - | - | - | [1] 28 28 💬 |
50 | Caffeic acid tablets | - | - | - | - | [1] 63 63 💬 |
51 | Caffeine | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine hydrate
💬 | [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
52 | Caffeine 100-200 mg BID | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine hydrate
💬 | [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
53 | Caffeine alkaloid | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine hydrate
💬 | [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
54 | Calcichew D3 | - | - | - | - | [1] 274 274 💬 |
55 | Calcichew D3 Forte | - | - | - | - | [1] 113 113 💬 |
56 | Calcichew tablets | - | - | - | - | [1] 274 274 💬 |
57 | CALCIFEDIOL | [1] Calcifediol Calcifediol | [1] Calcifediol
Calcifediol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 113 113 💬 |
58 | Calciferol | [1] Vitamin D Vitamin D | - | - | - | [1] 49 49 💬 |
59 | Calcineurin Inhibitors | - | - | - | - | [1] 50 50 💬 |
60 | Calcineurin inhibitors maintenance | - | - | - | - | [1] 67 67 💬 |
61 | Calcio | [1] Calcium Calcium | - | - | - | [4] 13 13, 96, 97, 274 💬 |
62 | Calcio carbonato | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [1] 274 274 💬 |
63 | CALCIO CARBONATO/COLECALCIFEROLO | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [1] 274 274 💬 |
64 | CALCIO FOLINATO DC.IT | [1] Calcium Calcium | - | - | - | [1] 13 13 💬 |
65 | Calcipotriene | [1] Calcipotriol Calcipotriol | [1] Calcipotriene
Calcipotriene
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 51 51 💬 |
66 | CALCIPOTRIOL | [1] Calcipotriol Calcipotriol | [1] Calcipotriene
Calcipotriene
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 36 36 💬 |
67 | Calcitonin | - | - | - | - | [1] 225 225 💬 |
68 | CALCITONIN (SALMON) | [1] Salmon, unspecified Salmon, unspecified | - | - | - | [1] 225 225 💬 |
69 | Calcitonin nasal spray (salmon) | [1] Salmon, unspecified Salmon, unspecified | - | - | - | [2] 96 96, 97 💬 |
70 | Calcitriol | [1] Calcitriol Calcitriol | [1] Calcitriol
Calcitriol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [9] 18 18, 37, 46, 49, 66, 96, 158, 235, 326 💬 |
71 | Calcitriol & Calcium | [2] Calcitriol Calcitriol, Calcium | [1] Calcitriol
Calcitriol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 235 235 💬 |
72 | Calcium | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [27] 6 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
73 | Calcium and cholecalciferol | [2] Calcium Calcium, Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 46 46 💬 |
74 | Calcium and Vit D | [1] Calcium Calcium | - | - | - | [1] 49 49 💬 |
75 | Calcium and Vitamin D combination | [2] Calcium Calcium, Vitamin D | - | - | - | [1] 13 13 💬 |
76 | Calcium carbonate | [3] Calcium Calcium, Calcium carbonate, Carbonate ion | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [8] 13 13, 19, 46, 53, 75, 96, 235, 299 💬 |
77 | Calcium carbonate and alphacalcidol | [3] Calcium Calcium, Calcium carbonate, Carbonate ion | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [1] 235 235 💬 |
78 | Calcium carbonate D | [3] Calcium Calcium, Calcium carbonate, Carbonate ion | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [1] 53 53 💬 |
79 | Calcium Channel Blockers | [1] Calcium Calcium | - | - | - | [1] 51 51 💬 |
80 | Calcium citrate | [3] Calcium Calcium, Calcium carbonate, Calcium citrate | [3] Calcium carbonate
Calcium carbonate
,
Calcium citrate
,
Calcium carbonate
💬 | - | - | [3] 46 46, 84, 235 💬 |
81 | Calcium Citrate with Vitamin D2 | [3] Calcium Calcium, Calcium citrate, Ergocalciferol | [2] Ergocalciferol
Ergocalciferol
,
Calcium citrate
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 84 84 💬 |
82 | Calcium D3 | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [1] 274 274 💬 |
83 | CALCIUM D3 SANDOZ - 1000 MG + 880 U.I. COMPRESSE EFFERVESCENTI 30 COMPRESSE DIVISIBILI | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [1] 274 274 💬 |
84 | Calcium gluconate | [2] Calcium Calcium, Calcium gluconate | [1] Calcium gluconate
Calcium gluconate
💬 | - | - | [3] 214 214, 215, 235 💬 |
85 | Calcium lactate | [2] Calcium Calcium, Calcium lactate | [2] Calcium lactate
Calcium lactate
,
Calcium lactate hydrate
💬 | - | - | [1] 235 235 💬 |
86 | Calcium levofolinate | [1] Calcium Calcium | - | - | - | [1] 13 13 💬 |
87 | Calcium rosuvastatin | [2] Calcium Calcium, Rosuvastatin | [1] Rosuvastatin
Rosuvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬 |
88 | Calcium, Dietary | [1] Calcium Calcium | - | - | - | [1] 298 298 💬 |
89 | CALD HR-D (High-Risk, Regimen C) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
90 | CALD HR-D (High-Risk, Regimen D) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
91 | CALD SR-A (Standard-Risk, Regimen A) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
92 | CALD SR-B (Standard-Risk, Regimen B) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬 |
93 | Calfactant | [1] Calfactant Calfactant | [1] Calfactant
Calfactant
💬 | - | - | [1] 299 299 💬 |
94 | Calogen | - | - | - | - | [1] 2 2 💬 |
95 | Caltrate | - | - | - | - | [1] 97 97 💬 |
96 | Caltrate Pill | - | - | - | - | [1] 96 96 💬 |
97 | Calvan (bevantolol hydrochloride) | [1] Bevantolol Bevantolol | - | - | - | [1] 8 8 💬 |
98 | Calvan® 100 mg | - | - | - | - | [1] 8 8 💬 |
99 | CALY-002 | - | - | - | - | [1] 98 98 💬 |
100 | CAM-3001 | [1] Mavrilimumab Mavrilimumab | [1] Mavrilimumab
Mavrilimumab
💬 | [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 💬 |
101 | CAM2043 | - | - | - | - | [1] 51 51 💬 |
102 | Camoteskimab (CERC-007, AVTX-007, AEVI-007) | - | - | - | - | [1] 107 107 💬 |
103 | Campath | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬 | [1] CD52 CD52 💬 | - | [12] 19 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
104 | Campath -1H | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬 | [1] CD52 CD52 💬 | - | [1] 65 65 💬 |
105 | Campath 1H | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬 | [1] CD52 CD52 💬 | - | [4] 60 60, 65, 164, 285 💬 |
106 | Campath, Busulfan, Clofarabine | [2] Busulfan Busulfan, Clofarabine | [2] Busulfan
Busulfan
,
Clofarabine
💬 | [3] POLA1 POLA1, POLA2, RRM1 💬 | [7] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 326 326 💬 |
107 | Campath, Chemo and/or TBI Allo SCT | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬 | [1] CD52 CD52 💬 | - | [3] 60 60, 62, 283 💬 |
108 | Campath, Fludarabine, Cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 284 💬 |
109 | Campath-1H | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬 | [1] CD52 CD52 💬 | - | [6] 19 19, 20, 60, 234, 285, 326 💬 |
110 | CAMPATH-1H (Alemtuzumab) | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬 | [1] CD52 CD52 💬 | - | [1] 60 60 💬 |
111 | Canakinumab | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬 | [1] IL1B IL1B 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [10] 46 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 |
112 | Canakinumab (ACZ885) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬 | [1] IL1B IL1B 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 106 106 💬 |
113 | Canakinumab (company code: ACZ885D) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬 | [1] IL1B IL1B 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 106 106 💬 |
114 | Canakinumab (investigational) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬 | [1] IL1B IL1B 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 46 46 💬 |
115 | Canakinumab (proposed) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬 | [1] IL1B IL1B 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 46 46 💬 |
116 | Canakinumab (WHO approval pending) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬 | [1] IL1B IL1B 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 106 106 💬 |
117 | Canakinumab Injection | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬 | [1] IL1B IL1B 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 46 46 💬 |
118 | Canakinumab Injection [Ilaris] | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬 | [1] IL1B IL1B 💬 | [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 113 113 💬 |
119 | Candesartan | [2] Candesartan Candesartan, Candesartan cilexetil | [2] Candesartan
Candesartan
,
Candesartan cilexetil
💬 | [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 58 58, 67 💬 |
120 | Candesartan and Cilnidipine | [2] Candesartan Candesartan, Cilnidipine | [2] Candesartan
Candesartan
,
Cilnidipine
💬 | [6] AGTR1 AGTR1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Apelin signaling pathway, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Renin secretion, Renin-angiotensin system, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬 |
121 | Candesartan plus non-CCB agents | [1] Candesartan Candesartan | [1] Candesartan
Candesartan
💬 | [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬 |
122 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [18] 6 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
123 | Cannabidiol (CBD) | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [7] 6 6, 13, 140, 144, 145, 156, 158 💬 |
124 | Cannabidiol , synthetic form | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 96 96 💬 |
125 | Cannabidiol / Dronabinol capsule 5 mg+2,5 mg | [2] Cannabidiol Cannabidiol, Dronabinol | [2] Dronabinol
Dronabinol
,
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬 |
126 | Cannabidiol Botanical Drug Substance (CBD BDS) | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬 |
127 | Cannabidiol capsule 5 mg | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬 |
128 | Cannabidiol Oral Solution | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [4] 140 140, 144, 145, 193 💬 |
129 | Cannabidiol Oral Solution, is known as Epidyolex 100 mg/mL oral solution and is the approved name in the EU. Epidiolex (cannabidiol) oral solution is the approved name in the US. | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 158 158 💬 |
130 | Cannabidiol tablet 10 mg | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 46 46, 271 💬 |
131 | Cannabidiol vaginal suppository | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 226 226 💬 |
132 | Cannabidiolo | - | - | - | - | [1] 156 156 💬 |
133 | Cannabidiolo (CBD) | - | - | - | - | [1] 156 156 💬 |
134 | CANNABINOL | [1] Cannabinol Cannabinol | - | - | - | [1] 36 36 💬 |
135 | Cannabinol (CBN) | [1] Cannabinol Cannabinol | - | - | - | [1] 36 36 💬 |
136 | Cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [7] 2 2, 6, 13, 19, 90, 96, 97 💬 |
137 | Cannabis Based Medicine Extract (Sativex) | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 13 13 💬 |
138 | Cannabis Oil | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 6 6 💬 |
139 | Cannabis Sativa extract Oromucosal spray | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 2 2 💬 |
140 | Cannabis sativa L., folium cum flore | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 19 19 💬 |
141 | Cannabis, Medical | [1] Medical Cannabis Medical Cannabis | - | - | - | [5] 2 2, 6, 13, 96, 97 💬 |
142 | Cannador | - | - | - | - | [1] 13 13 💬 |
143 | CAP-1002 | [1] CAP-1002 CAP-1002 | - | - | - | [1] 113 113 💬 |
144 | CAPILLAREMA | - | - | - | - | [1] 51 51 💬 |
145 | Capillary colchicine dosage in colchicine-resistant Familial Mediterranean Fever patients. | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬 | [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 266 266 💬 |
146 | CAPLACIZUMAB | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬 | [1] VWF VWF 💬 | [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬 |
147 | Caplacizumab (ALX-0081) | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬 | [1] VWF VWF 💬 | [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬 |
148 | Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) | [2] Caplacizumab Caplacizumab, Von Willebrand factor human | [1] Caplacizumab
Caplacizumab
💬 | [1] VWF VWF 💬 | [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬 |
149 | Caplacizumab (an anti-von Willebrand Factor Nanobody) | [2] Caplacizumab Caplacizumab, Von Willebrand factor human | [1] Caplacizumab
Caplacizumab
💬 | [1] VWF VWF 💬 | [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬 |
150 | Caprylic Triglyceride | [1] Tricaprylin Tricaprylin | - | - | - | [1] 13 13 💬 |
151 | Capsaicin | [1] Capsaicin Capsaicin | [1] Capsaicin
Capsaicin
💬 | [1] TRPV1 TRPV1 💬 | [2] Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [3] 6 6, 86, 226 💬 |
152 | Capsaicin vapor | [1] Capsaicin Capsaicin | [1] Capsaicin
Capsaicin
💬 | [1] TRPV1 TRPV1 💬 | [2] Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬 |
153 | Capsule di prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬 |
154 | Capsule fecal microbiota material (cap-FMT) | - | - | - | - | [1] 96 96 💬 |
155 | Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
156 | Capsules with 160 mg Teavigo (at least 94% EGCG) | [1] Epigallocatechin gallate Epigallocatechin gallate | - | - | - | [1] 13 13 💬 |
157 | Captopril | [1] Captopril Captopril | [1] Captopril
Captopril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [2] 17 17, 86 💬 |
158 | CAPTURE | [1] Bifenthrin Bifenthrin | - | - | - | [1] 46 46 💬 |
159 | Carbaglu | [1] Carglumic acid Carglumic acid | [1] Carglumic acid
Carglumic acid
💬 | [1] CPS1 CPS1 💬 | [6] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism 💬 | [2] 245 245, 246 💬 |
160 | Carbamazepine | [1] Carbamazepine Carbamazepine | [1] Carbamazepine
Carbamazepine
💬 | [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [3] 6 6, 13, 231 💬 |
161 | Carbasalate calcium | [2] Calcium Calcium, Carbaspirin calcium | [1] Carbaspirin calcium
Carbaspirin calcium
💬 | - | - | [1] 46 46 💬 |
162 | CARBIDOPA | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [7] 6 6, 13, 17, 90, 140, 164, 201 💬 |
163 | CARBIDOPA (CD) | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
164 | CARBIDOPA (FU) | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
165 | Carbidopa 20 mg | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
166 | Carbidopa 200mg oral dose | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 💬 |
167 | Carbidopa 27.5 mg | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
168 | Carbidopa 65 mg capsule | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
169 | Carbidopa and Levodopa 25mg/100mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
170 | Carbidopa and Levodopa Controlled Release Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
171 | Carbidopa and Levodopa Tablets, USP | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
172 | CARBIDOPA ANIDRA | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
173 | CARBIDOPA FU | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
174 | CARBIDOPA INN | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
175 | CARBIDOPA LEVODOPA | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
176 | CARBIDOPA MONOHYDRATE | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
177 | Carbidopa Pill | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
178 | Carbidopa, levodopa, entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
179 | Carbidopa- Levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
180 | Carbidopa-4'-Monophosphate | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
181 | Carbidopa-Levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
182 | Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
183 | Carbidopa/l-dopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
184 | Carbidopa/l-dopa/entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
185 | Carbidopa/levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
186 | Carbidopa/levodopa, as prescribed by treating physician | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
187 | Carbidopa/Levodopa, immediate release | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
188 | Carbidopa/Levodopa/Entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
189 | Carbidopamonohydraat | - | - | - | - | [1] 6 6 💬 |
190 | CARBODOPA LEVADOPA | - | - | - | - | [1] 6 6 💬 |
191 | Carbodopa/levadopa | - | - | - | - | [1] 6 6 💬 |
192 | Carbohydrates intake | - | - | - | - | [1] 257 257 💬 |
193 | CARBOLITHIUM | - | - | - | - | [1] 2 2 💬 |
194 | CARBOLITHIUM*100CPS 150MG | - | - | - | - | [1] 2 2 💬 |
195 | Carbomer | [1] Carbomer Carbomer | - | - | - | [1] 53 53 💬 |
196 | Carbomer 974P | [2] Carbomer Carbomer, Carbopol 974P | - | - | - | [1] 53 53 💬 |
197 | Carbon | [1] Activated charcoal Activated charcoal | - | - | - | [6] 6 6, 85, 86, 96, 97, 158 💬 |
198 | Carbon dioxide | [2] Activated charcoal Activated charcoal, Carbon dioxide | [1] Carbon dioxide
Carbon dioxide
💬 | - | - | [2] 97 97, 158 💬 |
199 | Carbon monoxide | [2] Activated charcoal Activated charcoal, Carbon monoxide | [1] Carbon monoxide
Carbon monoxide
💬 | - | - | [2] 85 85, 86 💬 |
200 | Carbon-14 BIA 28-6156 | [2] Activated charcoal Activated charcoal, BIA | - | - | - | [1] 6 6 💬 |
201 | Carbonate | [1] Carbonate ion Carbonate ion | - | - | - | [12] 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
202 | Carbonate de lithium | [1] Carbonate ion Carbonate ion | - | - | - | [1] 2 2 💬 |
203 | CARBONE VEGETALE | - | - | - | - | [1] 13 13 💬 |
204 | Carbone vegetale polvere | - | - | - | - | [1] 13 13 💬 |
205 | Carboplatin | [1] Carboplatin Carboplatin | [1] Carboplatin
Carboplatin
💬 | - | - | [4] 28 28, 34, 60, 85 💬 |
206 | Cardiac progenitor cell infusion | - | - | - | - | [2] 210 210, 211 💬 |
207 | Cardicor | - | - | - | - | [1] 113 113 💬 |
208 | Cardicor (Merck brand) | - | - | - | - | [1] 113 113 💬 |
209 | Cardiovascular profile | - | - | - | - | [1] 113 113 💬 |
210 | CARDURA | [1] Doxazosin Doxazosin | [1] Doxazosin
Doxazosin
💬 | [3] ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | [7] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬 |
211 | Care as usual | - | - | - | - | [1] 15 15 💬 |
212 | Carfilzomib | [1] Carfilzomib Carfilzomib | [1] Carfilzomib
Carfilzomib
💬 | [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬 |
213 | Carglumic Acid | [1] Carglumic acid Carglumic acid | [1] Carglumic acid
Carglumic acid
💬 | [1] CPS1 CPS1 💬 | [6] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism 💬 | [3] 245 245, 246, 251 💬 |
214 | Carglumic Acid (Carbaglu®) | [1] Carglumic acid Carglumic acid | [1] Carglumic acid
Carglumic acid
💬 | [1] CPS1 CPS1 💬 | [6] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism 💬 | [2] 245 245, 246 💬 |
215 | Carisbamate | [1] Carisbamate Carisbamate | [1] Carisbamate
Carisbamate
💬 | - | - | [1] 144 144 💬 |
216 | Carmustine | [1] Carmustine Carmustine | [1] Carmustine
Carmustine
💬 | - | - | [5] 11 11, 13, 14, 28, 60 💬 |
217 | Carmustine, etoposide, cytarabine, and melphalan (BEAM) | [4] Carmustine Carmustine, Cytarabine, Etoposide, Melphalan | [4] Etoposide
Etoposide
,
Cytarabine
,
Carmustine
,
Melphalan
💬 | [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [1] 13 13 💬 |
218 | Carnitine | [1] Levocarnitine Levocarnitine | [1] Levocarnitine
Levocarnitine
💬 | - | - | [9] 5 5, 13, 58, 86, 96, 97, 265, 298, 316 💬 |
219 | Carnosine | [1] Carnosine Carnosine | - | - | - | [2] 6 6, 13 💬 |
220 | Carnosine supplementation | [1] Carnosine Carnosine | - | - | - | [1] 6 6 💬 |
221 | Carnosine, capsulle, 2 g/day, 8 weeks | [1] Carnosine Carnosine | - | - | - | [1] 13 13 💬 |
222 | Carrageenan | - | - | - | - | [1] 97 97 💬 |
223 | Carvedilol | [1] Carvedilol Carvedilol | [1] Carvedilol
Carvedilol
💬 | [5] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 | [13] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 57 57, 86, 113, 210 💬 |
224 | CARVI EXTRACTUM FLUIDUM | - | - | - | - | [1] 97 97 💬 |
225 | CAS # in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid) | - | - | - | - | [1] 254 254 💬 |
226 | CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one | - | - | - | - | [1] 58 58 💬 |
227 | CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one | - | - | - | - | [1] 58 58 💬 |
228 | CAS No.: 7758-16-9 | - | - | - | - | [1] 166 166 💬 |
229 | CAS# in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid) | - | - | - | - | [1] 254 254 💬 |
230 | Casein | [1] Casein Casein | - | - | - | [1] 97 97 💬 |
231 | Casein glycomacropeptide (CGMP) | [1] Casein Casein | - | - | - | [1] 97 97 💬 |
232 | CASIMERSEN | [1] Casimersen Casimersen | [1] Casimersen
Casimersen
💬 | [1] DMD DMD 💬 | [4] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1] 113 113 💬 |
233 | Caspofungin | [1] Caspofungin Caspofungin | [1] Caspofungin
Caspofungin
💬 | - | - | [1] 60 60 💬 |
234 | CASPOFUNGIN ACETATE | [2] Acetate Acetate, Caspofungin | [1] Caspofungin
Caspofungin
💬 | - | - | [1] 60 60 💬 |
235 | CAT-1004 | - | - | - | - | [1] 113 113 💬 |
236 | CAT-354 | - | - | - | - | [1] 97 97 💬 |
237 | Catapres ampoules | [1] Clonidine Clonidine | [1] Clonidine
Clonidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
238 | Catapresan | - | - | - | - | [2] 65 65, 78 💬 |
239 | Catapresan 75 | - | - | - | - | [1] 78 78 💬 |
240 | Catapresan 75, Tabletten | - | - | - | - | [1] 65 65 💬 |
241 | Cathepsin S | - | - | - | - | [1] 53 53 💬 |
242 | Cathepsin S Inhibitor | - | - | - | - | [1] 53 53 💬 |
243 | Catridecacog | [1] Catridecacog Catridecacog | [1] Catridecacog
Catridecacog
💬 | - | - | [2] 97 97, 288 💬 |
244 | Caudal epidural injection | - | - | - | - | [1] 70 70 💬 |
245 | Caudal Epidural Injection with Celestone | - | - | - | - | [1] 70 70 💬 |
246 | Caudal Epidural Injection with DepoMedrol | - | - | - | - | [1] 70 70 💬 |
247 | Caudal Epidural Injection with generic Celestone | - | - | - | - | [1] 70 70 💬 |
248 | Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) | - | - | - | - | [1] 85 85 💬 |
249 | Cavosonstat | [1] Cavosonstat Cavosonstat | [1] Cavosonstat
Cavosonstat
💬 | - | - | [1] 299 299 💬 |
250 | Cayston | [1] Aztreonam Aztreonam | [1] Aztreonam
Aztreonam
💬 | - | - | [1] 299 299 💬 |
251 | Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler | [1] Aztreonam Aztreonam | [1] Aztreonam
Aztreonam
💬 | - | - | [1] 299 299 💬 |
252 | CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution | [1] Aztreonam Aztreonam | [1] Aztreonam
Aztreonam
💬 | - | - | [1] 299 299 💬 |
253 | CB-01-02 | - | - | - | - | [1] 97 97 💬 |
254 | CB-01-05-MMX | - | - | - | - | [1] 97 97 💬 |
255 | CB-280 | - | - | - | - | [1] 299 299 💬 |
256 | CBD | - | - | - | - | [13] 2 2, 6, 8, 13, 36, 46, 51, 140, 144, 145, 156, 158, 206 💬 |
257 | CBD - Oral Solution, is known as Epidiolex, and is the approved name in the USA. | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 140 140, 144 💬 |
258 | CBD - Oral Solution, is known as Epidyolex 100 mg/ml oral solution, | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 158 158 💬 |
259 | CBD - Oral Solution, is known as Epidyolex, and is the approved name | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 156 156 💬 |
260 | CBD - Solution Orale, conosciuto come Epidiolex, questo è il nome approvato negli Stati Uniti | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 156 156 💬 |
261 | CBD oil | - | - | - | - | [1] 51 51 💬 |
262 | CBD Oral solution, is known as Epidyolex and is the approved name in the EU | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 156 156 💬 |
263 | CBD soluzione orale nota come Epidyolex e con tale nome è stato approvato in UE | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 156 156 💬 |
264 | CBD-Oral Solution, is known as Epidiolex, and is the approved name in the USA. | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 158 158 💬 |
265 | CBDCA | [1] Carboplatin Carboplatin | [1] Carboplatin
Carboplatin
💬 | - | - | [1] 85 85 💬 |
266 | CBDV | [1] Cannabidivarin Cannabidivarin | - | - | - | [1] 193 193 💬 |
267 | CBDV Compound | [1] Cannabidivarin Cannabidivarin | - | - | - | [1] 193 193 💬 |
268 | CBN | - | - | - | - | [1] 36 36 💬 |
269 | CBP-307 | - | - | - | - | [1] 97 97 💬 |
270 | CC | - | - | - | - | [13] 28 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271 💬 |
271 | CC-100004 | - | - | - | - | [1] 84 84 💬 |
272 | CC-10004 | - | - | - | - | [5] 46 46, 56, 97, 162, 271 💬 |
273 | CC-220 | - | - | - | - | [1] 49 49 💬 |
274 | CC-220 0.3 mg Daily | - | - | - | - | [1] 84 84 💬 |
275 | CC-220 0.6mg Daily | - | - | - | - | [1] 84 84 💬 |
276 | CC-292 | - | - | - | - | [1] 46 46 💬 |
277 | CC-4047 | - | - | - | - | [2] 28 28, 51 💬 |
278 | CC-5013 | - | - | - | - | [2] 28 28, 96 💬 |
279 | CC-90001 | - | - | - | - | [1] 85 85 💬 |
280 | CC-930 | - | - | - | - | [1] 85 85 💬 |
281 | CC-93538 | - | - | - | - | [1] 98 98 💬 |
282 | CC-99677 | - | - | - | - | [1] 271 271 💬 |
283 | CC-99677 30mg Capsule | - | - | - | - | [1] 271 271 💬 |
284 | CC-99677 60mg Capsule | - | - | - | - | [1] 271 271 💬 |
285 | CC100 | - | - | - | - | [1] 2 2 💬 |
286 | CCD 1042 | - | - | - | - | [1] 152 152 💬 |
287 | CCD 1042, MD 9150000, Mepalon 1042, SPT316 | - | - | - | - | [2] 152 152, 206 💬 |
288 | CCD 1042, MD 9150000, Mepalon 1042, SPT3162 | - | - | - | - | [1] 152 152 💬 |
289 | CCI-779 | - | - | - | - | [2] 13 13, 46 💬 |
290 | CCP-020 | - | - | - | - | [1] 36 36 💬 |
291 | CCP-690-550-10 | - | - | - | - | [1] 107 107 💬 |
292 | CCR1 Antagonist | - | - | - | - | [1] 46 46 💬 |
293 | CCX 354 | - | - | - | - | [1] 46 46 💬 |
294 | CCX 354-C | - | - | - | - | [1] 46 46 💬 |
295 | CCX-354 | [1] CCX-354 CCX-354 | - | - | - | [1] 46 46 💬 |
296 | CCX-354-C | [1] CCX-354 CCX-354 | - | - | - | [1] 46 46 💬 |
297 | CCX140 | - | - | - | - | [1] 222 222 💬 |
298 | CCX140-B | - | - | - | - | [1] 222 222 💬 |
299 | CCX168 | - | - | - | - | [5] 43 43, 44, 66, 109, 222 💬 |
300 | CCX282-B | - | - | - | - | [1] 96 96 💬 |
301 | CCX354 | - | - | - | - | [1] 46 46 💬 |
302 | CCX354-C | - | - | - | - | [1] 46 46 💬 |
303 | CD | - | - | - | - | [8] 6 6, 13, 46, 51, 63, 96, 97, 265 💬 |
304 | CD-4 guided therapy interruption | - | - | - | - | [1] 265 265 💬 |
305 | CD-C-Food | - | - | - | - | [1] 96 96 💬 |
306 | CD-LD CR | - | - | - | - | [1] 6 6 💬 |
307 | CD-LD IR | - | - | - | - | [1] 6 6 💬 |
308 | CD19-directed humanised afucosylated monoclonal antibody | - | - | - | - | [1] 11 11 💬 |
309 | CD19/BCMA CAR T-cells | - | - | - | - | [2] 16 16, 61 💬 |
310 | CD3/CD19 depleted leukocytes | - | - | - | - | [1] 284 284 💬 |
311 | CD3/CD19 neg allogeneic BMT | - | - | - | - | [1] 65 65 💬 |
312 | CD3/CD19 negative allogeneic hematopoietic stem cells | - | - | - | - | [1] 65 65 💬 |
313 | CD3/CD19 negative hematopoietic stem cells | - | - | - | - | [1] 85 85 💬 |
314 | CD34 selected autologous hematopoietic cells | - | - | - | - | [1] 51 51 💬 |
315 | CD34 Stem Cell Selection Therapy | - | - | - | - | [3] 60 60, 65, 284 💬 |
316 | CD34+ | - | - | - | - | [1] 65 65 💬 |
317 | CD34+ CELLS | - | - | - | - | [1] 285 285 💬 |
318 | CD34+ cells transduced with ADA retrovir | - | - | - | - | [1] 65 65 💬 |
319 | CD34+ enriched, T Cell Depleted donor stem cell product | - | - | - | - | [1] 326 326 💬 |
320 | CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT | - | - | - | - | [1] 65 65 💬 |
321 | CD34+ selected cells | - | - | - | - | [1] 285 285 💬 |
322 | CD34+CELLS | - | - | - | - | [2] 65 65, 285 💬 |
323 | CD34+SC | - | - | - | - | [1] 51 51 💬 |
324 | CD45RA depleted leukocytes | - | - | - | - | [1] 284 284 💬 |
325 | CD62L- Tem | - | - | - | - | [1] 60 60 💬 |
326 | CD7 CAR T-cells | - | - | - | - | [3] 50 50, 96, 97 💬 |
327 | CDCA | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] Chenodiol
Chenodiol
💬 | [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 💬 |
328 | CDCA Weight-Based Dose TID | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] Chenodiol
Chenodiol
💬 | [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 💬 |
329 | CDED+PEN+dairy products | - | - | - | - | [1] 96 96 💬 |
330 | CDMARD | - | - | - | - | [1] 46 46 💬 |
331 | CDNF | - | - | - | - | [1] 6 6 💬 |
332 | CDP3194 | - | - | - | - | [1] 49 49 💬 |
333 | CDP323 | [1] CDP323 CDP323 | - | - | - | [1] 13 13 💬 |
334 | CDP6038 | - | - | - | - | [2] 46 46, 96 💬 |
335 | CDP6038 (olokizumab) | [1] Olokizumab Olokizumab | [1] Olokizumab
Olokizumab
💬 | [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 💬 |
336 | CDP7657 | - | - | - | - | [1] 49 49 💬 |
337 | CDP870 | - | - | - | - | [3] 46 46, 96, 271 💬 |
338 | CDP870 100mg | - | - | - | - | [1] 46 46 💬 |
339 | CDP870 200mg | - | - | - | - | [1] 46 46 💬 |
340 | CDP870 400mg | - | - | - | - | [1] 46 46 💬 |
341 | CDP870 Fab'-PEG | - | - | - | - | [1] 46 46 💬 |
342 | CDX | - | - | - | - | [2] 222 222, 240 💬 |
343 | CDX 6114 | - | - | - | - | [1] 240 240 💬 |
344 | CDX-1135 | - | - | - | - | [1] 222 222 💬 |
345 | CDZ173 | - | - | - | - | [2] 53 53, 65 💬 |
346 | CE 224,535 | - | - | - | - | [1] 46 46 💬 |
347 | CE-224,535 | - | - | - | - | [1] 46 46 💬 |
348 | CE-VST01-JC | [1] CE-VST01-JC CE-VST01-JC | - | - | - | [1] 25 25 💬 |
349 | CEBION 500*20CPR MAST 500MG | - | - | - | - | [1] 10 10 💬 |
350 | CEBION 500MG 20CPR MAST.ARAN | - | - | - | - | [1] 10 10 💬 |
351 | Cediranib | [1] Cediranib Cediranib | [1] Cediranib
Cediranib
💬 | [3] FLT1 FLT1, FLT4, KDR 💬 | [15] Breast cancer Breast cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 34 34 💬 |
352 | Cediranib Maleate | [1] Cediranib Cediranib | [1] Cediranib
Cediranib
💬 | [3] FLT1 FLT1, FLT4, KDR 💬 | [15] Breast cancer Breast cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 34 34 💬 |
353 | CEFALEXIN | [1] Cephalexin Cephalexin | [2] Cefalexin
Cefalexin
,
Cephalexin
💬 | - | - | [1] 299 299 💬 |
354 | Cefazolin | [1] Cefazolin Cefazolin | [1] Cefazolin
Cefazolin
💬 | - | - | [1] 291 291 💬 |
355 | Cefepime | [1] Cefepime Cefepime | [1] Cefepime
Cefepime
💬 | - | - | [2] 60 60, 299 💬 |
356 | CEFEPIME DIHYDROCHLORIDE MONOHYDRATE | [1] Cefepime Cefepime | [1] Cefepime
Cefepime
💬 | - | - | [1] 60 60 💬 |
357 | Cefiderocol | [1] Cefiderocol Cefiderocol | [1] Cefiderocol
Cefiderocol
💬 | - | - | [1] 299 299 💬 |
358 | Cefoperazone | [1] Cefoperazone Cefoperazone | [1] Cefoperazone
Cefoperazone
💬 | - | - | [1] 296 296 💬 |
359 | Ceftaroline | [1] Ceftaroline fosamil Ceftaroline fosamil | [1] Ceftaroline fosamil
Ceftaroline fosamil
💬 | - | - | [1] 299 299 💬 |
360 | Ceftazidim | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
361 | Ceftazidim Fresenius Kabi | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
362 | Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
363 | Ceftazidima | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
364 | CEFTAZIDIMA PENTAIDRATO | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
365 | CEFTAZIDIME | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
366 | Ceftazidime and tobramycin | [2] Ceftazidime Ceftazidime, Tobramycin | [3] Tobramycin
Tobramycin
,
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
367 | CEFTAZIDIME PENTAHYDRATE | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
368 | Ceftazidime/avibactam | [2] Avibactam Avibactam, Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
369 | Ceftolozane | [1] Ceftolozane Ceftolozane | [1] Ceftolozane
Ceftolozane
💬 | - | - | [1] 299 299 💬 |
370 | Ceftolozane/Tazobactam | [2] Ceftolozane Ceftolozane, Tazobactam | [2] Tazobactam
Tazobactam
,
Ceftolozane
💬 | - | - | [1] 299 299 💬 |
371 | Ceftriaxone | [1] Ceftriaxone Ceftriaxone | [1] Ceftriaxone
Ceftriaxone
💬 | - | - | [4] 2 2, 6, 46, 97 💬 |
372 | Cefuroxim | [1] Cefuroxime Cefuroxime | [1] Cefuroxime
Cefuroxime
💬 | - | - | [1] 299 299 💬 |
373 | Cefuroxime | [1] Cefuroxime Cefuroxime | [1] Cefuroxime
Cefuroxime
💬 | - | - | [2] 97 97, 299 💬 |
374 | CELBESTA® | - | - | - | - | [1] 46 46 💬 |
375 | Celebra | - | - | - | - | [1] 46 46 💬 |
376 | Celebra (celecoxib) | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬 |
377 | CELEBREX | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [4] 46 46, 96, 107, 271 💬 |
378 | Celebrex 200 mg | - | - | - | - | [1] 46 46 💬 |
379 | Celebrex 200 mg capsule, hard | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬 |
380 | Celebrex 200 mg Hartkapseln | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬 |
381 | CELEBREX 200MG 20CPS | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬 |
382 | Celebrex 200Mg Capsule | - | - | - | - | [1] 70 70 💬 |
383 | CELEBREX® | - | - | - | - | [1] 46 46 💬 |
384 | Celecoxib | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [10] 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 💬 |
385 | Celecoxib (Celebrex) | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 34 34 💬 |
386 | Celecoxib 200 milligrams | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬 |
387 | Celecoxib 200mg capsule | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬 |
388 | Celecoxib 400 milligrams | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬 |
389 | Celecoxib, Celebrex® | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬 |
390 | Celiprolol | [1] Celiprolol Celiprolol | [1] Celiprolol
Celiprolol
💬 | [1] ADRB1 ADRB1 💬 | [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 168 168 💬 |
391 | Cell transplantation | - | - | - | - | [1] 36 36 💬 |
392 | Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in ALS patients | - | - | - | - | [1] 2 2 💬 |
393 | Cellavita HD Higher dose | - | - | - | - | [1] 8 8 💬 |
394 | Cellavita HD Lower Dose | - | - | - | - | [1] 8 8 💬 |
395 | Cellavita-HD | - | - | - | - | [1] 8 8 💬 |
396 | CELLCEPT | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] Mycophenolate mofetil
Mycophenolate mofetil
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [5] 11 11, 13, 42, 43, 49 💬 |
397 | CellCept (Mycophenolate Mofetil) | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolic acid
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [2] 42 42, 43 💬 |
398 | CellCept 500 mg | - | - | - | - | [1] 11 11 💬 |
399 | CellCept 500 mg comprimidos recubiertos | - | - | - | - | [1] 35 35 💬 |
400 | CellCept 500 mg film-coated tablets | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] Mycophenolate mofetil
Mycophenolate mofetil
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 💬 |
401 | CellCept 500 mg tablets | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] Mycophenolate mofetil
Mycophenolate mofetil
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 💬 |
402 | CELLCEPT® | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] Mycophenolate mofetil
Mycophenolate mofetil
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 35 35 💬 |
403 | Cellcept® in autoimmune bullous dermatoses | - | - | - | - | [2] 35 35, 162 💬 |
404 | CellCept®500 mg comprimidos | - | - | - | - | [1] 35 35 💬 |
405 | CellCept®500 mg tablets | [1] Mycophenolate mofetil Mycophenolate mofetil | [1] Mycophenolate mofetil
Mycophenolate mofetil
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 11 11 💬 |
406 | Cellular therapy with EBV specific autologous CTL infusion | - | - | - | - | [1] 13 13 💬 |
407 | Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi | - | - | - | - | [1] 19 19 💬 |
408 | Celulas hepatocitos troncales adultas alogenicas de higado expandidas | - | - | - | - | [1] 251 251 💬 |
409 | Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida | - | - | - | - | [1] 274 274 💬 |
410 | Cemdisiran | [1] Cemdisiran Cemdisiran | - | - | - | [4] 11 11, 62, 66, 109 💬 |
411 | Cendakimab | - | - | - | - | [1] 98 98 💬 |
412 | Cenegermin | [1] Cenegermin Cenegermin | [1] Cenegermin
Cenegermin
💬 | [1] NGFR NGFR 💬 | [9] Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Lyssavirus 💬 | [1] 53 53 💬 |
413 | Cenerimod | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬 |
414 | Cenerimod 0.5 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬 |
415 | Cenerimod 1 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬 |
416 | Cenerimod 2 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬 |
417 | Cenerimod 4 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬 |
418 | Cenicriviroc | [1] Cenicriviroc Cenicriviroc | [1] Cenicriviroc
Cenicriviroc
💬 | [2] CCR2 CCR2, CCR5 💬 | [11] Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 94 94 💬 |
419 | Cenicriviroc 150 mg | [1] Cenicriviroc Cenicriviroc | [1] Cenicriviroc
Cenicriviroc
💬 | [2] CCR2 CCR2, CCR5 💬 | [11] Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 94 94 💬 |
420 | CENSAVUDINE | [1] Censavudine Censavudine | [1] Censavudine
Censavudine
💬 | - | - | [2] 2 2, 127 💬 |
421 | CEP-1347 | [1] CEP-1347 CEP-1347 | - | - | - | [1] 6 6 💬 |
422 | CEP-1347 10mg | [1] CEP-1347 CEP-1347 | - | - | - | [1] 6 6 💬 |
423 | CEP-1347 50mg | [1] CEP-1347 CEP-1347 | - | - | - | [1] 6 6 💬 |
424 | CEP-33457 | - | - | - | - | [1] 49 49 💬 |
425 | CEP1347 | - | - | - | - | [1] 6 6 💬 |
426 | CEP1347 25mg | - | - | - | - | [1] 6 6 💬 |
427 | Cephalexin | [1] Cephalexin Cephalexin | [2] Cefalexin
Cefalexin
,
Cephalexin
💬 | - | - | [1] 299 299 💬 |
428 | Cepharanthin | [1] Cepharanthine Cepharanthine | [1] Cepharanthine
Cepharanthine
💬 | - | - | [1] 53 53 💬 |
429 | Cepharanthine | [1] Cepharanthine Cepharanthine | [1] Cepharanthine
Cepharanthine
💬 | - | - | [1] 53 53 💬 |
430 | CER-001 | - | - | - | - | [1] 79 79 💬 |
431 | Ceralifimod | [1] Ceralifimod Ceralifimod | - | - | - | [1] 13 13 💬 |
432 | Ceralifmod | - | - | - | - | [1] 13 13 💬 |
433 | Ceramic on Polyethylene articulation | - | - | - | - | [1] 46 46 💬 |
434 | Cerazette | - | - | - | - | [1] 230 230 💬 |
435 | CERC-006 | - | - | - | - | [1] 278 278 💬 |
436 | Cerdelga | [1] Eliglustat Eliglustat | [1] Eliglustat
Eliglustat
💬 | [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
437 | CERE-120 | - | - | - | - | [1] 6 6 💬 |
438 | CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) | - | - | - | - | [1] 6 6 💬 |
439 | CERE-120: AAV2-NTN | - | - | - | - | [1] 6 6 💬 |
440 | CERE-120: Adeno-Associated Virus Delivery of Neurturin | - | - | - | - | [1] 6 6 💬 |
441 | Cerebral Dopamine Neurotrophic Factor | [1] Dopamine Dopamine | [1] Dopamine
Dopamine
💬 | [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
442 | Cerebro-spinal fluid | - | - | - | - | [1] 13 13 💬 |
443 | Ceredase | [1] Alglucerase Alglucerase | [1] Alglucerase
Alglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
444 | CEREDASE™ | [1] Alglucerase Alglucerase | [1] Alglucerase
Alglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
445 | Ceretec | [2] Cobalt chloride Cobalt chloride, Technetium Tc-99m exametazime | - | - | - | [1] 6 6 💬 |
446 | CERETEC (TM) Estabilizado | [2] Cobalt chloride Cobalt chloride, Technetium Tc-99m exametazime | - | - | - | [1] 6 6 💬 |
447 | CEREZYME | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
448 | Cerezyme (imiglucerase for injection) | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
449 | Cerezyme 400 Units Powder for concentrate for solution for infusion | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
450 | Cerezyme® | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
451 | Cerezyme® / Imiglucerase | [1] Imiglucerase Imiglucerase | [1] Imiglucerase
Imiglucerase
💬 | [1] GBA1 GBA1 💬 | [4] Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬 |
452 | Cerliponase Alfa | [1] Cerliponase alfa Cerliponase alfa | [1] Cerliponase alfa
Cerliponase alfa
💬 | [1] TPP1 TPP1 💬 | [1] Lysosome Lysosome 💬 | [1] 19 19 💬 |
453 | Certican | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [4] 67 67, 96, 158, 228 💬 |
454 | Certican 0,5 | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 228 228 💬 |
455 | Certican 0,5 mg Tabletten | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 228 228 💬 |
456 | Certican 0,75mg | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 228 228 💬 |
457 | Certican 0,75mg Tabletten | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 228 228 💬 |
458 | Certican 1 mg tablets | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 💬 |
459 | Certican Tabletten | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 67 67 💬 |
460 | Certolizumab | - | - | - | - | [5] 46 46, 49, 96, 270, 271 💬 |
461 | Certolizumab Pegol | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8] 37 37, 46, 49, 96, 97, 107, 226, 271 💬 |
462 | Certolizumab pegol (CDP870) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 💬 |
463 | Certolizumab pegol (CDP870, CZP) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬 |
464 | Certolizumab pegol (CDP870, tradename Cimzia) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
465 | Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
466 | Certolizumab Pegol (CZP) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 107, 271 💬 |
467 | Certolizumab Pegol (CZP) 200 mg | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
468 | Certolizumab Pegol (CZP) 400 mg | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
469 | Certolizumab pegol (rINN) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬 |
470 | Certolizumab Pegol + Methotrexate (MTX) | [2] Certolizumab pegol Certolizumab pegol, Methotrexate | [2] Methotrexate
Methotrexate
,
Certolizumab pegol
💬 | [3] DHFR DHFR, DHFR2, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
471 | Certolizumab pegol / CIMZIA | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬 |
472 | Certolizumab Pegol /Cimzia | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬 |
473 | Certolizumab Pegol 200 MG/ML [Cimzia] | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
474 | Certolizumab pegol 400 mg | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬 |
475 | CertolizumabPegol injection | - | - | - | - | [1] 46 46 💬 |
476 | CERTOLUZIMAB PEGOL | - | - | - | - | [1] 46 46 💬 |
477 | Cervarix | [4] Human papillomavirus type 16 L1 capsid protein antigen Human papillomavirus type 16 L1 capsid protein antigen, Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen, Human papillomavirus type 18 L1 capsid protein antigen, Human papillomavirus type 18 L1 capsid protein residues 2-472 antigen | - | - | - | [3] 49 49, 50, 107 💬 |
478 | Cervarix suspensie voor injectie | [4] Human papillomavirus type 16 L1 capsid protein antigen Human papillomavirus type 16 L1 capsid protein antigen, Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen, Human papillomavirus type 18 L1 capsid protein antigen, Human papillomavirus type 18 L1 capsid protein residues 2-472 antigen | - | - | - | [3] 49 49, 50, 107 💬 |
479 | Cesamet™ (nabilone) | [1] Nabilone Nabilone | [1] Nabilone
Nabilone
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬 |
480 | Ceterizine | - | - | - | - | [1] 13 13 💬 |
481 | Cetirizina | [1] Cetirizine Cetirizine | [1] Cetirizine
Cetirizine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 28, 300 💬 |
482 | CETIRIZINA DICLORIDRATO | [1] Cetirizine Cetirizine | [1] Cetirizine
Cetirizine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 28 28 💬 |
483 | Cetirizina Mylan Generics | [1] Cetirizine Cetirizine | [1] Cetirizine
Cetirizine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬 |
484 | CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU | [1] Cetirizine Cetirizine | [1] Cetirizine
Cetirizine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 300 300 💬 |
485 | Cetirizine | [1] Cetirizine Cetirizine | [1] Cetirizine
Cetirizine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 35 💬 |
486 | CETIRIZINE HYDROCHLORIDE | [1] Cetirizine Cetirizine | [1] Cetirizine
Cetirizine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬 |
487 | Cetrorelix | [1] Cetrorelix Cetrorelix | [1] Cetrorelix
Cetrorelix
💬 | [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬 |
488 | Cetuximab | [1] Cetuximab Cetuximab | [1] Cetuximab
Cetuximab
💬 | [1] EGFR EGFR 💬 | [48] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | [2] 51 51, 86 💬 |
489 | Cevidoplenib | - | - | - | - | [1] 46 46 💬 |
490 | Cevimeline | [1] Cevimeline Cevimeline | [1] Cevimeline
Cevimeline
💬 | [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 53 53 💬 |
491 | CF patients with a G551D mutation and treated with Ivacaftor | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬 | [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬 |
492 | CF101 | - | - | - | - | [1] 46 46 💬 |
493 | CF101 1 mg | - | - | - | - | [1] 46 46 💬 |
494 | CF101 2 mg | - | - | - | - | [1] 46 46 💬 |
495 | CFTR Modulators | - | - | - | - | [1] 299 299 💬 |
496 | CFTR potentiator | - | - | - | - | [1] 299 299 💬 |
497 | CFZ533 | - | - | - | - | [4] 11 11, 46, 49, 53 💬 |
498 | CFZ533 (iscalimab) | [1] Iscalimab Iscalimab | [1] Iscalimab
Iscalimab
💬 | [1] CD40 CD40 💬 | [17] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | [1] 53 53 💬 |
499 | CFZ533 active - Cohort 1 | - | - | - | - | [1] 53 53 💬 |
500 | CFZ533 active - Cohort 2 | - | - | - | - | [1] 53 53 💬 |
501 | CFZ533 active - Cohort 3 | - | - | - | - | [1] 53 53 💬 |
502 | CFZ533 active -Cohort 3 | - | - | - | - | [1] 53 53 💬 |
503 | CGMP protein | - | - | - | - | [1] 97 97 💬 |
504 | CGP 77116 | - | - | - | - | [1] 13 13 💬 |
505 | CH-1504 | - | - | - | - | [1] 46 46 💬 |
506 | CH-4051 | - | - | - | - | [1] 46 46 💬 |
507 | Ch11-1F4 (NSC-711516) | - | - | - | - | [1] 28 28 💬 |
508 | ChAdOx1 nCoV-19 | [1] AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | [3] 46 46, 51, 299 💬 |
509 | ChAdOx2 HAV | - | - | - | - | [1] 96 96 💬 |
510 | Chamomile | [1] Chamomile Chamomile | [1] German chamomile flower
German chamomile flower
💬 | - | - | [1] 6 6 💬 |
511 | Champix | [1] Varenicline Varenicline | [1] Varenicline
Varenicline
💬 | [2] CHRNA4 CHRNA4, CHRNB2 💬 | [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | [1] 6 6 💬 |
512 | Change in daily dosage of Growth Hormone | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
513 | Charcoal | - | - | - | - | [1] 13 13 💬 |
514 | Chelation | - | - | - | - | [1] 60 60 💬 |
515 | Chemical conjugate of recombinant human growth hormone (rhGH) and human immunoglobulin G4 fragment (HMC001) | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
516 | CHEMICALLY MODIFIED RECOMBINANT HUMAN SULFAMIDASE | - | - | - | - | [1] 19 19 💬 |
517 | Chemotherapy | - | - | - | - | [3] 28 28, 60, 285 💬 |
518 | Chenodeoxycholic acid | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] Chenodiol
Chenodiol
💬 | [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [4] 20 20, 96, 234, 263 💬 |
519 | Chenodiol | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] Chenodiol
Chenodiol
💬 | [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 96 96 💬 |
520 | Chenofalk | - | - | - | - | [1] 96 96 💬 |
521 | CHF 6333 | - | - | - | - | [1] 299 299 💬 |
522 | CHF10067 high dose | - | - | - | - | [1] 85 85 💬 |
523 | CHF10067 intermediate dose | - | - | - | - | [1] 85 85 💬 |
524 | CHF10067 starting dose | - | - | - | - | [1] 85 85 💬 |
525 | CHF6333 (Part 1 - SAD) | - | - | - | - | [1] 299 299 💬 |
526 | CHF6333 (Part 2 - MAD) | - | - | - | - | [1] 299 299 💬 |
527 | CHF6657 | - | - | - | - | [1] 19 19 💬 |
528 | Chicken | [1] Chicken Chicken | - | - | - | [1] 46 46 💬 |
529 | Chicken type II collagen | [1] Chicken Chicken | - | - | - | [1] 46 46 💬 |
530 | CHIMERIC FIBRIL-REACTIVE IGG1K MONOCLONAL ANTIBODY 11-1F4 | - | - | - | - | [1] 28 28 💬 |
531 | Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4 | - | - | - | - | [1] 28 28 💬 |
532 | Chimeric Human-Murine IgG1 | - | - | - | - | [1] 46 46 💬 |
533 | Chimeric human/mouse anti-CD-20 monoclonal antibody | - | - | - | - | [1] 46 46 💬 |
534 | Chimeric IgG1 monoclonal antibody | - | - | - | - | [1] 96 96 💬 |
535 | Chimeric monoclonal antibody, IgG4 subtype | - | - | - | - | [2] 43 43, 44 💬 |
536 | Chimeric murine human anti-IL-6 monoclonal antibody | - | - | - | - | [1] 331 331 💬 |
537 | Chinese Herb Prescription Granule plus prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬 |
538 | Chinese herbal concoction twice a day for 6 months | - | - | - | - | [1] 60 60 💬 |
539 | Chinese herbal medicine treatment | - | - | - | - | [1] 6 6 💬 |
540 | Chinese herbs based on syndrome differentiation | - | - | - | - | [1] 224 224 💬 |
541 | Chlor | [1] Chlorine Chlorine | - | - | - | [2] 46 46, 271 💬 |
542 | Chlorambucil | [1] Chlorambucil Chlorambucil | [1] Chlorambucil
Chlorambucil
💬 | - | - | [1] 222 222 💬 |
543 | Chlorhexidine | [1] Chlorhexidine Chlorhexidine | [1] Chlorhexidine
Chlorhexidine
💬 | - | - | [2] 86 86, 299 💬 |
544 | Chlorhexidine Gluconate | [1] Chlorhexidine Chlorhexidine | [1] Chlorhexidine
Chlorhexidine
💬 | - | - | [1] 299 299 💬 |
545 | Chlorhexidine gluconate oral rinse | [1] Chlorhexidine Chlorhexidine | [1] Chlorhexidine
Chlorhexidine
💬 | - | - | [1] 299 299 💬 |
546 | Chloride | [1] Chloride ion Chloride ion | - | - | - | [28] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬 |
547 | Chlorogenic Acid | [1] Chlorogenic Acid Chlorogenic Acid | - | - | - | [1] 97 97 💬 |
548 | Chloroquine | [1] Chloroquine Chloroquine | [1] Chloroquine
Chloroquine
💬 | - | - | [3] 46 46, 49, 95 💬 |
549 | Chloroquine diphosphate | [1] Chloroquine Chloroquine | [1] Chloroquine
Chloroquine
💬 | - | - | [1] 95 95 💬 |
550 | Chloroquine diphosphate 250mg | [1] Chloroquine Chloroquine | [1] Chloroquine
Chloroquine
💬 | - | - | [1] 95 95 💬 |
551 | Chlorothiazide | [1] Chlorothiazide Chlorothiazide | [1] Chlorothiazide
Chlorothiazide
💬 | [1] SLC12A3 SLC12A3 💬 | - | [1] 225 225 💬 |
552 | Chlorpromazine | [1] Chlorpromazine Chlorpromazine | [1] Chlorpromazine
Chlorpromazine
💬 | [13] ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬 | [22] Alcoholism Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 254 254 💬 |
553 | Chlorpromazine Hydrochloride | [1] Chlorpromazine Chlorpromazine | [1] Chlorpromazine
Chlorpromazine
💬 | [13] ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬 | [22] Alcoholism Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 254 254 💬 |
554 | CHLORURE DE SODIUM | - | - | - | - | [1] 96 96 💬 |
555 | Chocolate | [1] Cocoa Cocoa | - | - | - | [1] 6 6 💬 |
556 | CHOLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [9] 13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
557 | Cholecalciferol (Vitamin D3) | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [2] 13 13, 299 💬 |
558 | Cholecalciferol (vitaminD3) | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 299 299 💬 |
559 | Cholecalciferol 10,000 IU | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬 |
560 | Cholecalciferol 400 IU | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬 |
561 | Cholecalciferol and C. Xanthorrhiza | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 49 49 💬 |
562 | CHOLECALCIFEROL CONCENTRATE | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬 |
563 | CHOLECALCIFEROL CONCENTRATE (WATER-DISPERSIBLE FORM) | [2] Cholecalciferol Cholecalciferol, Water | [2] Water
Water
,
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬 |
564 | Cholecalciferol Pill | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 299 299 💬 |
565 | Cholecalciferol, Vitamin D3 | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 13 13 💬 |
566 | Cholestagel | [1] Colesevelam Colesevelam | [1] Colesevelam
Colesevelam
💬 | - | - | [1] 96 96 💬 |
567 | Cholesterol | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬 | - | - | [6] 8 8, 19, 90, 160, 222, 310 💬 |
568 | Cholesterol supplementation | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬 | - | - | [1] 310 310 💬 |
569 | Cholesterol Suspension | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬 | - | - | [1] 310 310 💬 |
570 | Cholestyramine | [1] Cholestyramine Cholestyramine | - | - | - | [2] 13 13, 79 💬 |
571 | Cholic Acid | [1] Cholic Acid Cholic Acid | [1] Cholic acid
Cholic acid
💬 | [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [4] 20 20, 234, 265, 310 💬 |
572 | Cholic Acids | - | - | - | - | [2] 20 20, 234 💬 |
573 | Choline | [1] Choline Choline | [1] Choline
Choline
💬 | - | - | [4] 93 93, 171, 193, 299 💬 |
574 | Choline Chloride | [2] Chloride ion Chloride ion, Choline | [1] Choline
Choline
💬 | - | - | [1] 299 299 💬 |
575 | Choline supplementation | [1] Choline Choline | [1] Choline
Choline
💬 | - | - | [1] 299 299 💬 |
576 | Chondroitin sulfate | [2] Chondroitin sulfate Chondroitin sulfate, Sulfate ion | - | - | - | [2] 96 96, 226 💬 |
577 | Chong Kun Dang Tofacitinib Tablet | [1] Tofacitinib Tofacitinib | [1] Tofacitinib
Tofacitinib
💬 | [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 💬 |
578 | CHR-1103 / GBR500 | - | - | - | - | [1] 13 13 💬 |
579 | Chromium | [1] Chromium Chromium | - | - | - | [1] 46 46 💬 |
580 | Chromosomal microarray analysis (CMA) and whole exome sequencing (WES) | - | - | - | - | [1] 179 179 💬 |
581 | Chronic Corticosteroid Therapy | - | - | - | - | [1] 113 113 💬 |
582 | Chronocort | - | - | - | - | [1] 81 81 💬 |
583 | Chronocort 10mg | - | - | - | - | [1] 81 81 💬 |
584 | Chronocort 5mg | - | - | - | - | [1] 81 81 💬 |
585 | Chronocort® | - | - | - | - | [1] 81 81 💬 |
586 | Chronocort® 10 mg | - | - | - | - | [1] 81 81 💬 |
587 | Chronocort® 20 mg | - | - | - | - | [1] 81 81 💬 |
588 | Chronocort® 5 mg | - | - | - | - | [1] 81 81 💬 |
589 | CHS-0214 | - | - | - | - | [1] 46 46 💬 |
590 | CHX A-DTPA anti-CD66 antibody | [1] Pentetic acid Pentetic acid | [1] Pentetic acid
Pentetic acid
💬 | - | - | [1] 28 28 💬 |
591 | CHX-A-DTPA-Anti-CD66 | [1] Pentetic acid Pentetic acid | [1] Pentetic acid
Pentetic acid
💬 | - | - | [1] 28 28 💬 |
592 | CI-984 | - | - | - | - | [1] 75 75 💬 |
593 | CI-984, 17AA70, PD 132301-2 | - | - | - | - | [1] 81 81 💬 |
594 | Cialis | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬 |
595 | CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 75 75 💬 |
596 | Cialis 10 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 113 💬 |
597 | Cialis 2.5 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 113 💬 |
598 | CIALIS 20 mg comprimidos recubiertos con película | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
599 | Cialis 20 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 113 💬 |
600 | Cialis 5 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 113 💬 |
601 | Cianocobalamina | [1] Cyanocobalamin Cyanocobalamin | [4] Cyanocobalamin
Cyanocobalamin
,
Cyanocobalamin Co 57
,
Cyanocobalamin Co 58
,
Cyanocobalamin Co 60
💬 | - | - | [1] 13 13 💬 |
602 | CIANOCOBALAMINA FU DC.IT | [1] Cyanocobalamin Cyanocobalamin | [4] Cyanocobalamin
Cyanocobalamin
,
Cyanocobalamin Co 57
,
Cyanocobalamin Co 58
,
Cyanocobalamin Co 60
💬 | - | - | [1] 13 13 💬 |
603 | Cibenzoline | [1] Cibenzoline Cibenzoline | [1] Cifenline
Cifenline
💬 | [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 58 58 💬 |
604 | Ciclesonide | [1] Ciclesonide Ciclesonide | [1] Ciclesonide
Ciclesonide
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 💬 |
605 | Cicletanine | [1] Cicletanine Cicletanine | [1] Cicletanine
Cicletanine
💬 | - | - | [1] 86 86 💬 |
606 | Cicletanine hydrochloride | [1] Cicletanine Cicletanine | [1] Cicletanine
Cicletanine
💬 | - | - | [1] 86 86 💬 |
607 | Ciclofosfamida | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 222 222 💬 |
608 | Ciclofosfamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 13 13 💬 |
609 | Ciclosporin | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [13] 26 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬 |
610 | Ciclosporin (Ciclosporinium) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
611 | CICLOSPORIN A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
612 | Ciclosporin Soft Capsule | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬 |
613 | CICLOSPORINA | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 49 49, 60, 97, 228 💬 |
614 | Ciclosporina / Ciclosporin | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
615 | Ciclosporina A Liposomica Aerolised Liposomal Ciclosporin A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
616 | Ciclosporina/ Ciclosporin | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
617 | Ciclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 60 60, 228 💬 |
618 | Ciclosporine A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
619 | Ciclosporine, Ciclosporina | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
620 | Cidofovir | [1] Cidofovir Cidofovir | [1] Cidofovir
Cidofovir
💬 | - | - | [1] 25 25 💬 |
621 | Ciklosporin | - | - | - | - | [1] 226 226 💬 |
622 | CILASTATIN | [1] Cilastatin Cilastatin | [1] Cilastatin
Cilastatin
💬 | [1] DPEP1 DPEP1 💬 | - | [2] 60 60, 299 💬 |
623 | Cilastatine | [1] Cilastatin Cilastatin | [1] Cilastatin
Cilastatin
💬 | [1] DPEP1 DPEP1 💬 | - | [1] 60 60 💬 |
624 | Cilazapril | [1] Cilazapril Cilazapril | [2] Cilazapril
Cilazapril
,
Cilazapril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 66 66 💬 |
625 | Ciliary neurotrophic factor | [1] Ciliary neurotrophic factor Ciliary neurotrophic factor | - | - | - | [1] 90 90 💬 |
626 | Ciliary Neurotrophic Factor Implant NT-501 | [1] Ciliary neurotrophic factor Ciliary neurotrophic factor | - | - | - | [1] 90 90 💬 |
627 | Cilnidipine | [1] Cilnidipine Cilnidipine | [1] Cilnidipine
Cilnidipine
💬 | [5] CACNA1B CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [41] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Nicotine addiction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬 |
628 | CILO | - | - | - | - | [1] 94 94 💬 |
629 | Cilofexor | [1] Cilofexor Cilofexor | - | - | - | [2] 93 93, 94 💬 |
630 | Cilostazol | [1] Cilostazol Cilostazol | [1] Cilostazol
Cilostazol
💬 | [3] PDE3A PDE3A, PDE3B, TBXA2R 💬 | [14] Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 46 46, 51, 70 💬 |
631 | Cilostazol 100 MG | [1] Cilostazol Cilostazol | [1] Cilostazol
Cilostazol
💬 | [3] PDE3A PDE3A, PDE3B, TBXA2R 💬 | [14] Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬 |
632 | Cimetidine | [1] Cimetidine Cimetidine | [1] Cimetidine
Cimetidine
💬 | [1] HRH2 HRH2 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | [2] 2 2, 254 💬 |
633 | Cimetidine plus Dexpramipexole | [2] Cimetidine Cimetidine, Dexpramipexole | [2] Cimetidine
Cimetidine
,
Dexpramipexole
💬 | [6] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, HRH2 💬 | [12] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 2 2 💬 |
634 | CIMZIA | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [5] 46 46, 49, 96, 97, 271 💬 |
635 | CIMZIA (Certolizumab Pegol) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
636 | CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
637 | CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI ALCOOL | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
638 | Cimzia 200 mg injeksjonsvæske, oppløsning | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
639 | Cimzia 200 mg solution for injection | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 271 💬 |
640 | CIMZIA certolizumab pegol 200 mg/ml solution for injection | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬 |
641 | Cimzia® | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 271 💬 |
642 | Cinacalcet | [1] Cinacalcet Cinacalcet | [1] Cinacalcet
Cinacalcet
💬 | [1] CASR CASR 💬 | [2] NOD-like receptor signaling pathway NOD-like receptor signaling pathway, Parathyroid hormone synthesis, secretion and action 💬 | [1] 238 238 💬 |
643 | CinnaTropin® | - | - | - | - | [1] 78 78 💬 |
644 | Cinryze | [1] Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | [2] 13 13, 61 💬 |
645 | CINRYZE® (C1 esterase inhibitor [human]) | [1] Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | [1] 61 61 💬 |
646 | Cipaglucosidase Alfa | [1] Cipaglucosidase alfa Cipaglucosidase alfa | [1] Cipaglucosidase alfa
Cipaglucosidase alfa
💬 | [1] GAA GAA 💬 | [4] Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | [1] 256 256 💬 |
647 | Cipaglucosidasi alfa | - | - | - | - | [1] 256 256 💬 |
648 | CIPRALEX | - | - | - | - | [1] 6 6 💬 |
649 | Cipro (Ciprofloxacin, BAYQ3939) | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
650 | Cipro Inhale | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
651 | Ciprofloxacin | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [5] 2 2, 60, 96, 97, 299 💬 |
652 | Ciprofloxacin (BAYQ3939) dry powder for inhalation | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
653 | Ciprofloxacin (Cipro Inhale, BAYQ3939) | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
654 | Ciprofloxacin (Cipro, BAYQ3939) | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
655 | Ciprofloxacin (ciproxin) | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
656 | Ciprofloxacin dispersion for inhalation | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
657 | Ciprofloxacin DPI | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
658 | Ciprofloxacin DPI (BAYQ3939) | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
659 | Ciprofloxacin for Inhalation | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
660 | Ciprofloxacin hydrochloride | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [2] 96 96, 299 💬 |
661 | CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
662 | Ciprofloxacin Inhale | [1] Ciprofloxacin Ciprofloxacin | [1] Ciprofloxacin
Ciprofloxacin
💬 | - | - | [1] 299 299 💬 |
663 | Ciprofloxacina | - | - | - | - | [1] 299 299 💬 |
664 | CIPROFLOXACINA CLORIDRATO | - | - | - | - | [1] 299 299 💬 |
665 | Ciproxin | - | - | - | - | [1] 299 299 💬 |
666 | CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE | - | - | - | - | [1] 299 299 💬 |
667 | Ciproxin Suspension | - | - | - | - | [1] 299 299 💬 |
668 | CIPROXIN*6CPR RIV 500MG | - | - | - | - | [1] 299 299 💬 |
669 | Circadin | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬 | [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [3] 6 6, 13, 90 💬 |
670 | Circadin ( INN= Melatonin) | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬 | [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬 |
671 | Circadin 2 mg | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬 | [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 90 90 💬 |
672 | CIRCADIN 2 mg comprimidos de liberación prolongada | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬 | [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 90 90 💬 |
673 | Circadin® | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬 | [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬 |
674 | Cis-4-Hydroxy-L-Proline | [1] Proline Proline | [1] Proline
Proline
💬 | - | - | [1] 94 94 💬 |
675 | CISAPRIDE | [1] Cisapride Cisapride | [2] Cisapride
Cisapride
,
Cisapride
💬 | [3] HTR2A HTR2A, HTR3A, HTR4 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬 |
676 | Cisplatin | [1] Cisplatin Cisplatin | [1] Cisplatin
Cisplatin
💬 | - | - | [1] 28 28 💬 |
677 | Cistanche Total Glycosides | - | - | - | - | [1] 2 2 💬 |
678 | Citalopram | [1] Citalopram Citalopram | [1] Citalopram
Citalopram
💬 | [1] SLC6A4 SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [7] 6 6, 8, 13, 18, 46, 98, 127 💬 |
679 | Citalopram 20mg | [1] Citalopram Citalopram | [1] Citalopram
Citalopram
💬 | [1] SLC6A4 SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 6 6 💬 |
680 | Citicolin | - | - | - | - | [1] 6 6 💬 |
681 | CITICOLIN*1G/4ML IM IV 5 F | - | - | - | - | [1] 6 6 💬 |
682 | Citicolina | [1] Citicoline Citicoline | [1] Citicoline
Citicoline
💬 | - | - | [1] 6 6 💬 |
683 | Citicolina 1000 mg/die | [1] Citicoline Citicoline | [1] Citicoline
Citicoline
💬 | - | - | [1] 6 6 💬 |
684 | CITICOLINA SODICA | [1] Citicoline Citicoline | [1] Citicoline
Citicoline
💬 | - | - | [1] 6 6 💬 |
685 | CITOCHINE ED IMMUNOMODULATORI | - | - | - | - | [1] 13 13 💬 |
686 | Citocoline | - | - | - | - | [1] 205 205 💬 |
687 | Citric acid | [1] Citric acid Citric acid | [1] Citric acid monohydrate
Citric acid monohydrate
💬 | - | - | [2] 53 53, 291 💬 |
688 | Citric Acid based Mouthwash | [1] Citric acid Citric acid | [1] Citric acid monohydrate
Citric acid monohydrate
💬 | - | - | [1] 53 53 💬 |
689 | Citrulline | [1] Citrulline Citrulline | - | - | - | [2] 86 86, 113 💬 |
690 | CJH1 (CLR4001) | - | - | - | - | [1] 6 6 💬 |
691 | CJNJ-68150420-ZZZ-G001 (ACT- 064992D) | - | - | - | - | [1] 86 86 💬 |
692 | CJNJ-68150420-ZZZ-G001 (ACT-064992D) | - | - | - | - | [1] 86 86 💬 |
693 | CJNJ-68150420-ZZZ-G001(ACT-064992D) | - | - | - | - | [1] 86 86 💬 |
694 | CK-2017357 | - | - | - | - | [1] 2 2 💬 |
695 | CK-2017357 (Part A) | - | - | - | - | [1] 2 2 💬 |
696 | CK-2017357 (Part B) | - | - | - | - | [1] 2 2 💬 |
697 | CK-2127107 | [1] Reldesemtiv Reldesemtiv | [1] Reldesemtiv
Reldesemtiv
💬 | [1] TNNC2 TNNC2 💬 | [1] Calcium signaling pathway Calcium signaling pathway 💬 | [1] 2 2 💬 |
698 | CK-3773274 | - | - | - | - | [1] 58 58 💬 |
699 | CK-3773274 (10 - 30 mg) | - | - | - | - | [1] 58 58 💬 |
700 | CK-3773274 (5 - 15 mg) | - | - | - | - | [1] 58 58 💬 |
701 | CK-3773274 (5 - 20 mg) | - | - | - | - | [1] 58 58 💬 |
702 | CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg) | - | - | - | - | [1] 58 58 💬 |
703 | CK-3773274 - Granules in Capsule | - | - | - | - | [1] 58 58 💬 |
704 | CK-3773274 - Tablets | - | - | - | - | [1] 58 58 💬 |
705 | CK0803 | - | - | - | - | [1] 2 2 💬 |
706 | CK2017357 | - | - | - | - | [1] 2 2 💬 |
707 | CKD-374 5mg Tab. | - | - | - | - | [1] 46 46 💬 |
708 | CKD-504 | - | - | - | - | [1] 8 8 💬 |
709 | CKD-506 | - | - | - | - | [1] 46 46 💬 |
710 | CL20-i4-EF1a-h?c-OPT | - | - | - | - | [1] 65 65 💬 |
711 | CLA | - | - | - | - | [1] 97 97 💬 |
712 | CLA (Chlorogenic acid) | [1] Chlorogenic Acid Chlorogenic Acid | - | - | - | [1] 97 97 💬 |
713 | CLADRIBINA | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬 |
714 | Cladribina oral | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬 |
715 | CLADRIBINE | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [3] 11 11, 13, 94 💬 |
716 | Cladribine (MAVENCLAD®) | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬 |
717 | Cladribine 3.5 mg/kg | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬 |
718 | Cladribine 5.25 mg/kg | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬 |
719 | Cladribine Oral Tablet | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬 |
720 | Cladribine Pill | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬 |
721 | Cladribine Tablet | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬 |
722 | Cladribine Tablets | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬 |
723 | Cladrybine | - | - | - | - | [1] 11 11 💬 |
724 | Clarithromycin | [1] Clarithromycin Clarithromycin | [1] Clarithromycin
Clarithromycin
💬 | - | - | [8] 6 6, 63, 84, 96, 97, 222, 228, 299 💬 |
725 | Clarithromycin (Not used as of 4/2020) | [1] Clarithromycin Clarithromycin | [1] Clarithromycin
Clarithromycin
💬 | - | - | [1] 6 6 💬 |
726 | Claritromycin | - | - | - | - | [1] 299 299 💬 |
727 | Claritromycin 500mg film coated tablets | - | - | - | - | [1] 299 299 💬 |
728 | Clarium 50 mg Retardtabletten | - | - | - | - | [1] 6 6 💬 |
729 | Clartihromycin, amoxicillin, and omeprazole | [2] Amoxicillin Amoxicillin, Omeprazole | [3] Amoxicillin
Amoxicillin
,
Omeprazole
,
Amoxicillin
💬 | [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 6 6 💬 |
730 | Classic DMARDs treatment group | - | - | - | - | [1] 46 46 💬 |
731 | Classical ketogenic diet | - | - | - | - | [1] 137 137 💬 |
732 | Clasteon | [1] Clodronic acid Clodronic acid | [1] Clodronic acid
Clodronic acid
💬 | - | - | [1] 274 274 💬 |
733 | Clavulanate | [1] Clavulanic acid Clavulanic acid | [1] Clavulanic acid
Clavulanic acid
💬 | - | - | [1] 299 299 💬 |
734 | CLAVULANIC ACID | [1] Clavulanic acid Clavulanic acid | [1] Clavulanic acid
Clavulanic acid
💬 | - | - | [1] 299 299 💬 |
735 | CLAZAKIZUMAB | [1] Clazakizumab Clazakizumab | [1] Clazakizumab
Clazakizumab
💬 | - | - | [1] 46 46 💬 |
736 | CLBS12 | - | - | - | - | [1] 47 47 💬 |
737 | CLE | - | - | - | - | [1] 6 6 💬 |
738 | Clemastine | [1] Clemastine Clemastine | [1] Clemastine
Clemastine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬 |
739 | CLEMASTINE FUMARATE | [1] Clemastine Clemastine | [1] Clemastine
Clemastine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬 |
740 | Clemastine Milstein 1 mg, tabletten | [1] Clemastine Clemastine | [1] Clemastine
Clemastine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬 |
741 | Clemizole | [1] Clemizole Clemizole | - | - | - | [2] 140 140, 144 💬 |
742 | Clemizole HCl | [1] Clemizole Clemizole | - | - | - | [1] 144 144 💬 |
743 | CLEMIZOLE HYDROCHLORIDE | [1] Clemizole Clemizole | - | - | - | [1] 140 140 💬 |
744 | Clenbuterol | [1] Clenbuterol Clenbuterol | [1] Clenbuterol
Clenbuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 1 1, 2, 6, 256 💬 |
745 | Clenbuterol HCl | [1] Clenbuterol Clenbuterol | [1] Clenbuterol
Clenbuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
746 | CLENBUTEROL HYDROCHLORIDE | [1] Clenbuterol Clenbuterol | [1] Clenbuterol
Clenbuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
747 | Clindamycin | [1] Clindamycin Clindamycin | [1] Clindamycin
Clindamycin
💬 | - | - | [2] 46 46, 299 💬 |
748 | Clipper | - | - | - | - | [1] 97 97 💬 |
749 | Clipper 30 cpr 5mg R.M. | - | - | - | - | [1] 97 97 💬 |
750 | CLIPPER*30CPR 5MG R.M. | - | - | - | - | [1] 97 97 💬 |
751 | Clobazam | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 140 140, 144 💬 |
752 | Clobazam High Dose | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬 |
753 | Clobazam Low Dose | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬 |
754 | Clobazam Medium Dose | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬 |
755 | Clobazam PhEur | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬 |
756 | Clobazam Tablets | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬 |
757 | Clobazam Tablets 10mg | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬 |
758 | Clobazam Tablets 20mg | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬 |
759 | Clobazam Tablets 5mg | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬 |
760 | Clobetasol | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [4] 39 39, 46, 51, 162 💬 |
761 | Clobetasol 0.05% ointment | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 39 39 💬 |
762 | Clobetasol 0.05% Topical Ointment | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬 |
763 | Clobetasol Propionate | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 162 💬 |
764 | Clobetasol propionate + Methotrexate | [3] Clobetasol Clobetasol, Clobetasol propionate, Methotrexate | [3] Methotrexate
Methotrexate
,
Clobetasol propionate
,
Clobetasol
💬 | [3] DHFR DHFR, DHFR2, NR3C1 💬 | [6] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | [1] 162 162 💬 |
765 | Clobetasol propionate alone | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬 |
766 | Clobetasol Propionate cream treatment | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬 |
767 | Clofarabine | [1] Clofarabine Clofarabine | [1] Clofarabine
Clofarabine
💬 | [3] POLA1 POLA1, POLA2, RRM1 💬 | [7] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [5] 19 19, 20, 60, 234, 326 💬 |
768 | CLOFAZIMINE | [1] Clofazimine Clofazimine | [1] Clofazimine
Clofazimine
💬 | - | - | [1] 96 96 💬 |
769 | Clomiphene | [1] Clomifene Clomifene | [1] Clomifene
Clomifene
💬 | [2] ESR1 ESR1, ESR2 💬 | [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 74 74 💬 |
770 | Clomiphene citrate | [1] Clomifene Clomifene | [1] Clomifene
Clomifene
💬 | [2] ESR1 ESR1, ESR2 💬 | [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 74 74 💬 |
771 | Clonazepam | [1] Clonazepam Clonazepam | [1] Clonazepam
Clonazepam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 6 6 💬 |
772 | Clonidin | [1] Clonidine Clonidine | [1] Clonidine
Clonidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 78 78 💬 |
773 | Clonidina | [1] Clonidine Clonidine | [1] Clonidine
Clonidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 78 78 💬 |
774 | CLONIDINA CLORIDRATO | [1] Clonidine Clonidine | [1] Clonidine
Clonidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 78 78 💬 |
775 | Clonidine | [1] Clonidine Clonidine | [1] Clonidine
Clonidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [4] 6 6, 65, 70, 78 💬 |
776 | Clonidine HCl CF 0,150 mg, tabletten | [1] Clonidine Clonidine | [1] Clonidine
Clonidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 78 78 💬 |
777 | Clonidine hydrochloride | [1] Clonidine Clonidine | [1] Clonidine
Clonidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [2] 6 6, 78 💬 |
778 | Clonidinhydrochlorid | - | - | - | - | [1] 65 65 💬 |
779 | Clopidogrel | [1] Clopidogrel Clopidogrel | [3] Clopidogrel
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬 | [1] P2RY12 P2RY12 💬 | [1] Platelet activation Platelet activation 💬 | [3] 49 49, 51, 86 💬 |
780 | Clopidogrel treatment | [1] Clopidogrel Clopidogrel | [3] Clopidogrel
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬 | [1] P2RY12 P2RY12 💬 | [1] Platelet activation Platelet activation 💬 | [1] 51 51 💬 |
781 | Clorfenamina | [1] Chlorpheniramine Chlorpheniramine | [1] Chlorphenamine
Chlorphenamine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 14 14 💬 |
782 | CLORFENAMINA MALEATO | [1] Chlorpheniramine Chlorpheniramine | [1] Chlorphenamine
Chlorphenamine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 14 14 💬 |
783 | Cloruro de Sodio | - | - | - | - | [1] 228 228 💬 |
784 | CLORURO SODICO 7% | - | - | - | - | [1] 299 299 💬 |
785 | Clostridium botulinum | [1] Clostridium botulinum Clostridium botulinum | - | - | - | [1] 13 13 💬 |
786 | CLOSTRIDIUM BOTULINUM TOXIN TYPE A | [2] Botulinum toxin type A Botulinum toxin type A, Clostridium botulinum | [1] Botulinum toxin type A
Botulinum toxin type A
💬 | [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 13 13 💬 |
787 | Clotrimazole | [1] Clotrimazole Clotrimazole | [1] Clotrimazole
Clotrimazole
💬 | - | - | [1] 97 97 💬 |
788 | CLOZAPINE | [1] Clozapine Clozapine | [1] Clozapine
Clozapine
💬 | [11] ADRA2A ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | [8] Calcium signaling pathway Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
789 | CLS | - | - | - | - | [1] 2 2 💬 |
790 | CLTX-305 | - | - | - | - | [1] 235 235 💬 |
791 | Cluvot | - | - | - | - | [1] 288 288 💬 |
792 | CM-101 | - | - | - | - | [1] 94 94 💬 |
793 | CM310 | - | - | - | - | [1] 300 300 💬 |
794 | CMAB008 | - | - | - | - | [1] 46 46 💬 |
795 | CME-LEM4 | - | - | - | - | [1] 117 117 💬 |
796 | CMK389 | - | - | - | - | [1] 84 84 💬 |
797 | CNM-Au8 | - | - | - | - | [2] 2 2, 13 💬 |
798 | CNMAu8 | - | - | - | - | [1] 2 2 💬 |
799 | CNP-104 | - | - | - | - | [1] 93 93 💬 |
800 | Cnp-MS-0601 | - | - | - | - | [1] 13 13 💬 |
801 | CNS10-NPC implantation | - | - | - | - | [1] 90 90 💬 |
802 | CNS10-NPC-GDNF | - | - | - | - | [1] 2 2 💬 |
803 | CNSA-001 | - | - | - | - | [1] 240 240 💬 |
804 | CNT-02 | - | - | - | - | [1] 160 160 💬 |
805 | CNTO 1275 | - | - | - | - | [2] 13 13, 96 💬 |
806 | CNTO 136 | - | - | - | - | [2] 41 41, 46 💬 |
807 | CNTO 136 100 mg | - | - | - | - | [1] 46 46 💬 |
808 | CNTO 136 25 mg | - | - | - | - | [1] 46 46 💬 |
809 | CNTO 136 50 mg | - | - | - | - | [1] 46 46 💬 |
810 | CNTO 136 IgG | - | - | - | - | [1] 46 46 💬 |
811 | CNTO 148 | - | - | - | - | [4] 46 46, 84, 97, 271 💬 |
812 | CNTO 148 (Golimumab) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 💬 |
813 | CNTO 1959 | - | - | - | - | [1] 46 46 💬 |
814 | CNTO 1959 + MTX (Group 4) | - | - | - | - | [1] 46 46 💬 |
815 | CNTO 1959 + MTX (Group 5) | - | - | - | - | [1] 46 46 💬 |
816 | CNTO 1959 IgG | - | - | - | - | [1] 46 46 💬 |
817 | CNTO 2476 | - | - | - | - | [1] 90 90 💬 |
818 | CNTO 328 | - | - | - | - | [1] 331 331 💬 |
819 | CNTO 6785 100 mg | - | - | - | - | [1] 46 46 💬 |
820 | CNTO 6785 15 mg | - | - | - | - | [1] 46 46 💬 |
821 | CNTO 6785 200 mg | - | - | - | - | [1] 46 46 💬 |
822 | CNTO 6785 50 mg | - | - | - | - | [1] 46 46 💬 |
823 | CNTO 888 1 mg/kg | - | - | - | - | [1] 85 85 💬 |
824 | CNTO 888 15 mg/kg | - | - | - | - | [1] 85 85 💬 |
825 | CNTO 888 5 mg/kg | - | - | - | - | [1] 85 85 💬 |
826 | CNTO-148 | - | - | - | - | [1] 97 97 💬 |
827 | CNTO1275 | - | - | - | - | [6] 46 46, 49, 84, 93, 96, 97 💬 |
828 | CNTO136 | - | - | - | - | [1] 46 46 💬 |
829 | CNTO148 | - | - | - | - | [5] 46 46, 84, 96, 97, 107 💬 |
830 | CNTO1959 | - | - | - | - | [4] 37 37, 41, 96, 97 💬 |
831 | CNTO312 | - | - | - | - | [1] 97 97 💬 |
832 | CNTO328 | - | - | - | - | [1] 331 331 💬 |
833 | CNTO6785 | - | - | - | - | [1] 46 46 💬 |
834 | CNTO888 | - | - | - | - | [1] 85 85 💬 |
835 | CO | - | - | - | - | [3] 13 13, 53, 85 💬 |
836 | CO-14 | - | - | - | - | [1] 13 13 💬 |
837 | Co-medication: Synthetic DMARDs | - | - | - | - | [1] 46 46 💬 |
838 | CO-TRIMOXAZOLE | - | - | - | - | [1] 85 85 💬 |
839 | Coagadex | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬 |
840 | Coagulación factor VIII | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
841 | Coagulation factor VIII | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
842 | Coagulation factor X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬 |
843 | Coagulation factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬 |
844 | Coamoxiclav | - | - | - | - | [1] 97 97 💬 |
845 | Coarse wheat bran | [2] Wheat Wheat, Wheat bran | [1] Wheat
Wheat
💬 | - | - | [1] 6 6 💬 |
846 | Cobalt | [1] Cobalt Cobalt | - | - | - | [1] 46 46 💬 |
847 | Cobamamide | [1] Cobamamide Cobamamide | [1] Cobamamide
Cobamamide
💬 | - | - | [1] 299 299 💬 |
848 | Cobimetinib | [1] Cobimetinib Cobimetinib | [1] Cobimetinib
Cobimetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 280 280 💬 |
849 | Cobiprostone | [1] Cobiprostone Cobiprostone | [1] Cobiprostone
Cobiprostone
💬 | - | - | [1] 46 46 💬 |
850 | COBITOLIMOD | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬 | [1] TLR9 TLR9 💬 | [9] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬 |
851 | Cobitolimod 250 mg | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬 | [1] TLR9 TLR9 💬 | [9] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬 |
852 | Cobitolimod 500 mg | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬 | [1] TLR9 TLR9 💬 | [9] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬 |
853 | Cobitolimod 500mg | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬 | [1] TLR9 TLR9 💬 | [9] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬 |
854 | Cocoa | [1] Cocoa Cocoa | - | - | - | [1] 6 6 💬 |
855 | Coconut | [1] Coconut Coconut | - | - | - | [1] 13 13 💬 |
856 | Coconut oil | [2] Coconut Coconut, Coconut oil | [1] Coconut oil
Coconut oil
💬 | - | - | [1] 13 13 💬 |
857 | Coconut oil and epigallocatechin gallate | [4] Coconut Coconut, Coconut oil, Epigallocatechin, Epigallocatechin gallate | [1] Coconut oil
Coconut oil
💬 | - | - | [1] 13 13 💬 |
858 | Cod | - | - | - | - | [1] 46 46 💬 |
859 | Cod liver oil | [1] Cod liver oil Cod liver oil | [1] Cod liver oil
Cod liver oil
💬 | - | - | [1] 46 46 💬 |
860 | Coenzym Q10 Nanodispersion | - | - | - | - | [1] 5 5 💬 |
861 | Coenzym Q10, Ubiquinon, Ubichinon | - | - | - | - | [1] 5 5 💬 |
862 | Coenzyme A | [1] Coenzyme A Coenzyme A | - | - | - | [1] 246 246 💬 |
863 | Coenzyme Q-10 | [1] Ubidecarenone Ubidecarenone | [1] Ubidecarenone
Ubidecarenone
💬 | - | - | [1] 86 86 💬 |
864 | Coenzyme Q-10 in Normal Control subjects | [1] Ubidecarenone Ubidecarenone | [1] Ubidecarenone
Ubidecarenone
💬 | - | - | [1] 86 86 💬 |
865 | Coenzyme Q-10 in Pulmonary Hypertension subjects | [1] Ubidecarenone Ubidecarenone | [1] Ubidecarenone
Ubidecarenone
💬 | - | - | [1] 86 86 💬 |
866 | Coenzyme Q10 | [1] Ubidecarenone Ubidecarenone | [1] Ubidecarenone
Ubidecarenone
💬 | - | - | [11] 2 2, 5, 6, 8, 10, 18, 46, 57, 113, 214, 215 💬 |
867 | Coenzyme Q10 and Lisinopril | [2] Lisinopril Lisinopril, Ubidecarenone | [3] Lisinopril
Lisinopril
,
Ubidecarenone
,
Lisinopril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 113 113 💬 |
868 | Coenzyme Q10 Nanodispersion (Nanoquinone) | [1] Ubidecarenone Ubidecarenone | [1] Ubidecarenone
Ubidecarenone
💬 | - | - | [1] 6 6 💬 |
869 | Coenzyme Q10 with vitamin E | [2] Ubidecarenone Ubidecarenone, Vitamin E | [2] Ubidecarenone
Ubidecarenone
,
Vitamin E
💬 | - | - | [1] 6 6 💬 |
870 | CoenzymeQ10 | - | - | - | - | [1] 21 21 💬 |
871 | CoFactor | - | - | - | - | [2] 265 265, 288 💬 |
872 | Cofactor supplementation (thiamine, riboflavin, L-carnitine) | [3] Levocarnitine Levocarnitine, Riboflavin, Thiamine | [3] Riboflavin
Riboflavin
,
Levocarnitine
,
Thiamine
💬 | - | - | [1] 265 265 💬 |
873 | Coffee | [2] Arabica coffee bean Arabica coffee bean, Coffea arabica seed, roasted | - | - | - | [1] 97 97 💬 |
874 | COFFEE COAL | [2] Arabica coffee bean Arabica coffee bean, Coffea arabica seed, roasted | - | - | - | [1] 97 97 💬 |
875 | Cogane | - | - | - | - | [1] 6 6 💬 |
876 | Cogane™ (PYM50028) | - | - | - | - | [1] 6 6 💬 |
877 | Cohort 1 0.225g | - | - | - | - | [1] 240 240 💬 |
878 | Cohort 1: 1.0 x 10^8 PolyTregs | - | - | - | - | [1] 35 35 💬 |
879 | Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 | [1] Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | [1] 60 60 💬 |
880 | Cohort 1:Nilotinib Oral Capsules (150mg or 300mg) | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬 | [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | [33] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 6 6 💬 |
881 | Cohort 2 0.75g | - | - | - | - | [1] 240 240 💬 |
882 | Cohort 2: 2.5x10^8 PolyTregs | - | - | - | - | [1] 35 35 💬 |
883 | Cohort 2: hATG, CsA, EPAG Day 14 to Month 3 | [1] Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | [1] 60 60 💬 |
884 | Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1) | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬 | [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | [33] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 6 6 💬 |
885 | Cohort 3 2.25 g | - | - | - | - | [1] 240 240 💬 |
886 | Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6 | [1] Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | - | - | - | [1] 60 60 💬 |
887 | Cohort1 | - | - | - | - | [1] 6 6 💬 |
888 | Cohort2 | - | - | - | - | [1] 6 6 💬 |
889 | COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin | - | - | - | - | [1] 36 36 💬 |
890 | COLAL PRED | - | - | - | - | [1] 97 97 💬 |
891 | COLAL-PRED | - | - | - | - | [1] 97 97 💬 |
892 | COLAL-PRED® | - | - | - | - | [1] 97 97 💬 |
893 | Colazide | - | - | - | - | [1] 97 97 💬 |
894 | COLCHICINA | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬 | [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 2 2 💬 |
895 | COLCHICINA LIRCA - 1 MG COMPRESSE 60 COMPRESSE | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬 | [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 2 2 💬 |
896 | Colchicine | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬 | [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [7] 2 2, 42, 46, 56, 93, 210, 266 💬 |
897 | Colchicine 1 MG Oral Tablet | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬 | [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 2 2 💬 |
898 | Colchicine sprinkle capsules | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬 | [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 266 266 💬 |
899 | Cold Cadioplegia | - | - | - | - | [1] 215 215 💬 |
900 | COLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [4] 13 13, 46, 96, 228 💬 |
901 | COLECALCIFEROL CONCENTRATE (OILY FORM) | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 13 13 💬 |
902 | Colecalciferol D3 (Vigantol Oil) | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬 |
903 | Colesevelam | [1] Colesevelam Colesevelam | [1] Colesevelam
Colesevelam
💬 | - | - | [2] 96 96, 260 💬 |
904 | Colestipol | [1] Colestipol Colestipol | [1] Colestipol
Colestipol
💬 | - | - | [1] 254 254 💬 |
905 | COLESTIRAMINA | [1] Cholestyramine Cholestyramine | - | - | - | [1] 13 13 💬 |
906 | COLESTYRAMINE | [1] Cholestyramine Cholestyramine | - | - | - | [1] 254 254 💬 |
907 | Colfinair 2 MIU Powder for Nebuliser Solution | - | - | - | - | [1] 299 299 💬 |
908 | Colimicina | - | - | - | - | [1] 299 299 💬 |
909 | COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML | - | - | - | - | [1] 299 299 💬 |
910 | Colimycine | - | - | - | - | [1] 299 299 💬 |
911 | COLIMYCINE inhalation | - | - | - | - | [1] 299 299 💬 |
912 | COLIMYCINE injectable | - | - | - | - | [1] 299 299 💬 |
913 | COLISTIMETATO SODICO | - | - | - | - | [1] 299 299 💬 |
914 | Colistimethat-Natrium | - | - | - | - | [1] 299 299 💬 |
915 | COLISTIMETHATE | [1] Colistimethate Colistimethate | - | - | - | [1] 299 299 💬 |
916 | Colistimethate 75 mg inhaled two times daily | [1] Colistimethate Colistimethate | - | - | - | [1] 299 299 💬 |
917 | COLISTIMETHATE SODIUM | [1] Colistimethate Colistimethate | - | - | - | [1] 299 299 💬 |
918 | COLISTIMETHATE SODIUM (A COMPONENT) | [1] Colistimethate Colistimethate | - | - | - | [1] 299 299 💬 |
919 | Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate | [2] Colistimethate Colistimethate, Colistin | [1] Colistin
Colistin
💬 | - | - | [1] 299 299 💬 |
920 | Colistimethate sodium (CMS) | [1] Colistimethate Colistimethate | - | - | - | [1] 299 299 💬 |
921 | Colistimethate sodium (promixin) | [1] Colistimethate Colistimethate | - | - | - | [1] 299 299 💬 |
922 | COLISTIN | [1] Colistin Colistin | [1] Colistin
Colistin
💬 | - | - | [1] 299 299 💬 |
923 | Colistin CF | [1] Colistin Colistin | [1] Colistin
Colistin
💬 | - | - | [1] 299 299 💬 |
924 | Colistin Forest - Trockenstechampullen mit Lösungsmittel | [1] Colistin Colistin | [1] Colistin
Colistin
💬 | - | - | [1] 299 299 💬 |
925 | COLISTIN MESILATE SODIUM | [1] Colistin Colistin | [1] Colistin
Colistin
💬 | - | - | [1] 299 299 💬 |
926 | Colistineb | - | - | - | - | [1] 299 299 💬 |
927 | COLISTINEB 2MUI | - | - | - | - | [1] 299 299 💬 |
928 | Collect of 10 ml of peripheric blood for DNA extraction | - | - | - | - | [1] 46 46 💬 |
929 | Collection of biological sample (blood and/or CSF) | - | - | - | - | [2] 2 2, 6 💬 |
930 | Collection of blood and urine | - | - | - | - | [1] 25 25 💬 |
931 | Collection of samples | - | - | - | - | [4] 49 49, 65, 95, 107 💬 |
932 | Collection of samples of blood and urine | - | - | - | - | [1] 167 167 💬 |
933 | Colobreathe | [1] Colistimethate Colistimethate | - | - | - | [1] 299 299 💬 |
934 | Colomycin | - | - | - | - | [1] 299 299 💬 |
935 | Colonoscopic fecal microbiota material (colo-FMT) | - | - | - | - | [1] 96 96 💬 |
936 | Colony-purified Bacteroides thetaiotaomicron (B.theta) | - | - | - | - | [1] 96 96 💬 |
937 | ColoVit capsule | - | - | - | - | [1] 96 96 💬 |
938 | Coltect | - | - | - | - | [1] 97 97 💬 |
939 | Combination | - | - | - | - | [1] 46 46 💬 |
940 | Combination antiviral therapy | - | - | - | - | [1] 93 93 💬 |
941 | Combination fish oil and borage seed oil | [1] Fish oil Fish oil | - | - | - | [1] 46 46 💬 |
942 | Combination injection of EPO and G-CSF | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬 | [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 6 6 💬 |
943 | Combination of a single dose anti-CD20 antibody and bortezomib | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬 | [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 61 61 💬 |
944 | Combination of DMARDs | - | - | - | - | [1] 107 107 💬 |
945 | Combination of fish oil and colesevelam | [2] Colesevelam Colesevelam, Fish oil | [1] Colesevelam
Colesevelam
💬 | - | - | [1] 260 260 💬 |
946 | Combination of Minocycline and MTX or MTX alone | [1] Minocycline Minocycline | [1] Minocycline
Minocycline
💬 | - | - | [1] 46 46 💬 |
947 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine | [3] Azathioprine Azathioprine, Dexamethasone, Rituximab | [3] Azathioprine
Azathioprine
,
Dexamethasone
,
Rituximab
💬 | [2] MS4A1 MS4A1, NR3C1 💬 | [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬 |
948 | Combination of Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬 |
949 | Combination of Rituximab with subcutaneous belimumab | [2] Belimumab Belimumab, Rituximab | [2] Rituximab
Rituximab
,
Belimumab
💬 | [2] MS4A1 MS4A1, TNFSF13B 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 63 63 💬 |
950 | Combination of thrombopoietin mimetic and cyclosporin A | [2] Cyclosporine Cyclosporine, Thrombopoietin | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬 |
951 | Combination Oral Budesonide and Rectal Hydrocortisone | [2] Budesonide Budesonide, Hydrocortisone | [2] Hydrocortisone
Hydrocortisone
,
Budesonide
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬 |
952 | Combination Product: | - | - | - | - | [1] 86 86 💬 |
953 | Combination Product: Active treatment with dual therapy | - | - | - | - | [1] 2 2 💬 |
954 | Combination Product: Beclomethasone dipropionate in addition to MC-EVOO | [1] Beclomethasone dipropionate Beclomethasone dipropionate | [1] Beclomethasone dipropionate
Beclomethasone dipropionate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬 |
955 | Combination Product: Beclomethasone dipropionate in addition to refined oil | [1] Beclomethasone dipropionate Beclomethasone dipropionate | [1] Beclomethasone dipropionate
Beclomethasone dipropionate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬 |
956 | Combination Product: Belimumab | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬 | [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬 |
957 | Combination Product: EGCG 300 mg + Nintedanib | [2] Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | [1] Nintedanib
Nintedanib
💬 | [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 💬 |
958 | Combination Product: EGCG 300 mg + Pirfenidone | [2] Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | [1] Pirfenidone
Pirfenidone
💬 | [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬 |
959 | Combination Product: EGCG 600 mg + Nintedanib | [2] Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | [1] Nintedanib
Nintedanib
💬 | [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 💬 |
960 | Combination Product: EGCG 600 mg + Pirfenidone | [2] Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | [1] Pirfenidone
Pirfenidone
💬 | [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬 |
961 | Combination Product: Exercise, and methotrexate | [1] Methotrexate Methotrexate | [1] Methotrexate
Methotrexate
💬 | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 💬 |
962 | Combination Product: Goldic serum | - | - | - | - | [1] 70 70 💬 |
963 | Combination Product: high MCT formula | - | - | - | - | [1] 296 296 💬 |
964 | Combination Product: Humira (adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬 |
965 | Combination Product: Implantable System for Remodulin (treprostinil) | [1] Treprostinil Treprostinil | [1] Treprostinil
Treprostinil
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬 |
966 | Combination Product: L-dopa 140 mg | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬 | [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
967 | Combination Product: L-dopa 35 mg | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬 | [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
968 | Combination Product: L-dopa 70mg | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬 | [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
969 | Combination Product: L-dopa 70mg/carbidopa 7mg | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
970 | Combination Product: Laser, exercise, and methotrexate | [1] Methotrexate Methotrexate | [1] Methotrexate
Methotrexate
💬 | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 💬 |
971 | Combination Product: lipid injectable emulsion with Fish oil | [1] Fish oil Fish oil | - | - | - | [1] 294 294 💬 |
972 | Combination Product: mavrilimumab | [1] Mavrilimumab Mavrilimumab | [1] Mavrilimumab
Mavrilimumab
💬 | [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 41 41 💬 |
973 | Combination Product: Methotrexate | [1] Methotrexate Methotrexate | [1] Methotrexate
Methotrexate
💬 | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 💬 |
974 | Combination Product: ND0612 Solution for SC infusion | - | - | - | - | [1] 6 6 💬 |
975 | Combination Product: ofatumumab with AI | [1] Ofatumumab Ofatumumab | [1] Ofatumumab
Ofatumumab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬 |
976 | Combination Product: ofatumumab with PRF | [1] Ofatumumab Ofatumumab | [1] Ofatumumab
Ofatumumab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬 |
977 | Combination Product: PRP combined Magnovision | - | - | - | - | [1] 90 90 💬 |
978 | Combination Product: Ravulizumab OBDS | [1] Ravulizumab Ravulizumab | [1] Ravulizumab
Ravulizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬 |
979 | Combination Product: Sanacoach Parkinson (SCP) | - | - | - | - | [1] 6 6 💬 |
980 | Combination Product: TransCon PTH | - | - | - | - | [1] 235 235 💬 |
981 | Combination Product: Treprostinil via implanted pump | [1] Treprostinil Treprostinil | [1] Treprostinil
Treprostinil
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬 |
982 | Combination Steroid | - | - | - | - | [1] 46 46 💬 |
983 | Combination therapy with vigabatrin and prednisolone | [2] Prednisolone Prednisolone, Vigabatrin | [2] Prednisolone
Prednisolone
,
Vigabatrin
💬 | [2] ABAT ABAT, NR3C1 💬 | [8] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 💬 |
984 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 85 85 💬 |
985 | COMBIVIR | [2] Lamivudine Lamivudine, Zidovudine | [2] Lamivudine
Lamivudine
,
Zidovudine
💬 | - | - | [1] 265 265 💬 |
986 | Combivir (zidovudine [AZT] / lamivudine [3TC]) | [2] Lamivudine Lamivudine, Zidovudine | [2] Lamivudine
Lamivudine
,
Zidovudine
💬 | - | - | [1] 265 265 💬 |
987 | Comirnaty | [1] Tozinameran Tozinameran | [1] Tozinameran
Tozinameran
💬 | - | - | [5] 13 13, 46, 51, 53, 299 💬 |
988 | Comirnaty concentrate for dispersion for injection | [1] Tozinameran Tozinameran | [1] Tozinameran
Tozinameran
💬 | - | - | [2] 53 53, 299 💬 |
989 | Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion | [1] Tozinameran Tozinameran | [1] Tozinameran
Tozinameran
💬 | - | - | [1] 13 13 💬 |
990 | Commercial Formulation Etanercept | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬 | [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
991 | Commercial Ventavis® (iloprost) | [1] Iloprost Iloprost | [1] Iloprost
Iloprost
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬 |
992 | Common Name: Sialic Acid | - | - | - | - | [1] 30 30 💬 |
993 | Comparator: carbidopa | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
994 | Comparator: diclofenac | [1] Diclofenac Diclofenac | [1] Diclofenac
Diclofenac
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬 |
995 | Comparator: Diclofenac sodium | [1] Diclofenac Diclofenac | [1] Diclofenac
Diclofenac
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬 |
996 | Comparator: ezetimibe | [1] Ezetimibe Ezetimibe | [1] Ezetimibe
Ezetimibe
💬 | [1] NPC1L1 NPC1L1 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [2] 79 79, 260 💬 |
997 | Comparator: levodopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬 | [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
998 | Comparator: naproxen tablet 500 mg | [1] Naproxen Naproxen | [1] Naproxen
Naproxen
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬 |
999 | COMPLEMENT C1 ESTERASE INHIBITOR | [1] Conestat alfa Conestat alfa | [1] Conestat alfa
Conestat alfa
💬 | [3] C1R C1R, C1S, KLKB1 💬 | [6] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 💬 |
1000 | Compound 1a | - | - | - | - | [2] 246 246, 299 💬 |
1001 | COMPOUND 21 | - | - | - | - | [1] 85 85 💬 |
1002 | Compound thrombosis capsule sig: 1.5g/tid | - | - | - | - | [1] 90 90 💬 |
1003 | Compressa effervescente 0,5 mg di budesonide per uso orodispersibile | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬 |
1004 | Compressa effervescente 1 mg di budesonide per uso orodispersibile | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬 |
1005 | COMTAN | [1] Entacapone Entacapone | [1] Entacapone
Entacapone
💬 | [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 💬 |
1006 | COMTAN 200* 60 CPR 200 MG | [1] Entacapone Entacapone | [1] Entacapone
Entacapone
💬 | [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 💬 |
1007 | COMTAN® | [1] Entacapone Entacapone | [1] Entacapone
Entacapone
💬 | [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 💬 |
1008 | Comtan® | - | - | - | - | [1] 6 6 💬 |
1009 | Comtess | [1] Entacapone Entacapone | [1] Entacapone
Entacapone
💬 | [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 💬 |
1010 | Comtess® | - | - | - | - | [1] 6 6 💬 |
1011 | Concentration unit: mg milligram(s) | - | - | - | - | [1] 254 254 💬 |
1012 | Concerta | - | - | - | - | [1] 203 203 💬 |
1013 | Conditioned Medium (CM) | - | - | - | - | [1] 90 90 💬 |
1014 | Confortid | - | - | - | - | [1] 225 225 💬 |
1015 | Conivaptan | [1] Conivaptan Conivaptan | [1] Conivaptan
Conivaptan
💬 | [2] AVPR1A AVPR1A, AVPR2 💬 | [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | [1] 86 86 💬 |
1016 | Conjugated equine estrogens | [1] Conjugated estrogens Conjugated estrogens | [1] Estrogens, conjugated
Estrogens, conjugated
💬 | - | - | [1] 49 49 💬 |
1017 | Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d | [1] Conjugated estrogens Conjugated estrogens | [1] Estrogens, conjugated
Estrogens, conjugated
💬 | - | - | [1] 49 49 💬 |
1018 | Conjugated pneumococcal vaccine (Prevenar) | - | - | - | - | [1] 65 65 💬 |
1019 | Conscious sedation | - | - | - | - | [1] 6 6 💬 |
1020 | Continuation of azathioprine | [1] Azathioprine Azathioprine | [1] Azathioprine
Azathioprine
💬 | - | - | [1] 49 49 💬 |
1021 | Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs) | - | - | - | - | [1] 265 265 💬 |
1022 | Continue IS (B cell depletion therapy) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬 |
1023 | Continue IS (MMF or MPA) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬 |
1024 | Continue IS (MTX) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬 |
1025 | Continued Ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] Ocrelizumab
Ocrelizumab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬 |
1026 | Continuous Apomorphine infusion | [1] Apomorphine Apomorphine | [1] Apomorphine
Apomorphine
💬 | [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1027 | Continuous infusion Cefepime | [1] Cefepime Cefepime | [1] Cefepime
Cefepime
💬 | - | - | [1] 299 299 💬 |
1028 | Continuous infusion Ceftazidime | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬 | - | - | [1] 299 299 💬 |
1029 | Continuous infusion Meropenem | [1] Meropenem Meropenem | [2] Meropenem
Meropenem
,
Meropenem
💬 | - | - | [1] 299 299 💬 |
1030 | Continuous infusion Piperacillin tazobactam | [2] Piperacillin Piperacillin, Tazobactam | [3] Tazobactam
Tazobactam
,
Piperacillin
,
Piperacillin
💬 | - | - | [1] 299 299 💬 |
1031 | Continuous infusion Ticarcillin-clavulanate | [2] Clavulanic acid Clavulanic acid, Ticarcillin | [2] Clavulanic acid
Clavulanic acid
,
Ticarcillin
💬 | - | - | [1] 299 299 💬 |
1032 | Continuous intrajejunal infusion of levodopa-carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1033 | Continuous oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬 | - | - | [1] 90 90 💬 |
1034 | Continuous Release Dopamine Agonists | [1] Dopamine Dopamine | [1] Dopamine
Dopamine
💬 | [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1035 | Continuous Subcutaneous Lisuride Infusion | [1] Lisuride Lisuride | [1] Lisuride
Lisuride
💬 | [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1036 | Contrast enhanced ultrasound | - | - | - | - | [1] 96 96 💬 |
1037 | Contrast Enhanced Voiding Urosonography with Urodynamic Testing | - | - | - | - | [1] 118 118 💬 |
1038 | Control | - | - | - | - | [4] 6 6, 46, 168, 299 💬 |
1039 | Control gel | - | - | - | - | [1] 36 36 💬 |
1040 | Control group | - | - | - | - | [4] 2 2, 13, 46, 70 💬 |
1041 | Control Group 0.9% Isotonic Saline | - | - | - | - | [1] 299 299 💬 |
1042 | Control intervention (no dexamethasone) | [1] Dexamethasone Dexamethasone | [1] Dexamethasone
Dexamethasone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬 |
1043 | Control multivitamin | - | - | - | - | [1] 299 299 💬 |
1044 | Controlled-release levodopa / carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1045 | Convection enhanced delivery/AAV2-GDNF | - | - | - | - | [1] 6 6 💬 |
1046 | Conventional | - | - | - | - | [1] 63 63 💬 |
1047 | Conventional DMARD combination | - | - | - | - | [1] 46 46 💬 |
1048 | Conventional DMARDs | - | - | - | - | [1] 46 46 💬 |
1049 | Conventional drug therapy(expectorant,bronchodilator) | - | - | - | - | [1] 86 86 💬 |
1050 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) | [7] Acetate Acetate, Cortisone, Cortisone acetate, Dexamethasone, Hydrocortisone, Prednisolone, Prednisone | [6] Hydrocortisone
Hydrocortisone
,
Dexamethasone
,
Prednisolone
,
Prednisone
,
Cortisone acetate
,
Cortisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬 |
1051 | Conventional medication | - | - | - | - | [1] 6 6 💬 |
1052 | Conventional synthetic antirheumatic drugs | - | - | - | - | [1] 46 46 💬 |
1053 | Conventional Synthetic DMARD | - | - | - | - | [1] 46 46 💬 |
1054 | Conventional therapy | - | - | - | - | [2] 67 67, 222 💬 |
1055 | Conventional therapy users for the last 5 years | - | - | - | - | [1] 271 271 💬 |
1056 | Conventional treatment | - | - | - | - | [1] 97 97 💬 |
1057 | Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [2] 96 96, 97 💬 |
1058 | Coozar | - | - | - | - | [1] 167 167 💬 |
1059 | COP | - | - | - | - | [1] 13 13 💬 |
1060 | COP-1 | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1061 | COP-1/Copolymer-1 | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1062 | COPAXONE | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1063 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1064 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1065 | COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1066 | COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1067 | Copaxone 20 mg | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1068 | Copaxone 20 mg/ml | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1069 | COPAXONE 20 mg/ml solución inyectable en jeringa precargada | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1070 | Copaxone 20 mg/ml solución para inyección en jeringa precargada | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1071 | Copaxone 20 mg/ml Solution for Injection, pre-filled syringe | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1072 | Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1073 | Copaxone 20mg/ml Solution for Injection, pre-filled syringe | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1074 | Copaxone 40 mg/ml | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1075 | Copaxone 40 mg/ml solution for injection, pre-filled syringe | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1076 | Copaxone subcutaneous injection syringe | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1077 | COPAXONE*SC 28SIR 20MG/ML | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1078 | Copaxone-Teva | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1079 | Copaxone® | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1080 | Copegus | [1] Ribavirin Ribavirin | [1] Ribavirin
Ribavirin
💬 | - | - | [1] 2 2 💬 |
1081 | Copolymer 1 | - | - | - | - | [1] 13 13 💬 |
1082 | Copolymer-1 | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 💬 |
1083 | Copper | [1] Copper Copper | - | - | - | [4] 2 2, 169, 170, 171 💬 |
1084 | COPPER (64CU) CHLORIDE | [2] Chloride ion Chloride ion, Copper | - | - | - | [1] 171 171 💬 |
1085 | Copper Histidinate | [1] Copper Copper | - | - | - | [1] 169 169 💬 |
1086 | Copper Histidine | [2] Copper Copper, Histidine | [1] Histidine
Histidine
💬 | - | - | [2] 169 169, 170 💬 |
1087 | CoQ10 | - | - | - | - | [3] 5 5, 6, 8 💬 |
1088 | COQUN | - | - | - | - | [1] 90 90 💬 |
1089 | COR-003 | - | - | - | - | [1] 75 75 💬 |
1090 | Cord blood | - | - | - | - | [1] 60 60 💬 |
1091 | Cord blood sampling | - | - | - | - | [1] 227 227 💬 |
1092 | Cord Blood Transplant | - | - | - | - | [1] 60 60 💬 |
1093 | Cord Blood Units | - | - | - | - | [1] 60 60 💬 |
1094 | Cord sampling | - | - | - | - | [1] 227 227 💬 |
1095 | Corn | [1] Corn Corn | - | - | - | [2] 46 46, 240 💬 |
1096 | Corn oil capsules | [1] Corn Corn | - | - | - | [1] 46 46 💬 |
1097 | Corn/soy oil | [1] Corn Corn | - | - | - | [1] 240 240 💬 |
1098 | Cornstarch | [1] Starch, corn Starch, corn | [1] Corn starch
Corn starch
💬 | - | - | [2] 90 90, 257 💬 |
1099 | Cornstarch control | [1] Starch, corn Starch, corn | [1] Corn starch
Corn starch
💬 | - | - | [1] 90 90 💬 |
1100 | CORT125134 | [1] Relacorilant Relacorilant | [1] Relacorilant
Relacorilant
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 75 75 💬 |
1101 | Cortancyl | [1] Prednisone acetate Prednisone acetate | [1] Prednisone acetate
Prednisone acetate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 35 35, 41, 162 💬 |
1102 | CORTANCYL 20 mg | [1] Prednisone acetate Prednisone acetate | [1] Prednisone acetate
Prednisone acetate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 35 35, 162 💬 |
1103 | Cortancyl ® 1 mg | [1] Prednisone acetate Prednisone acetate | [1] Prednisone acetate
Prednisone acetate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬 |
1104 | Cortancyl ® 20 mg | [1] Prednisone acetate Prednisone acetate | [1] Prednisone acetate
Prednisone acetate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬 |
1105 | Cortancyl ® 5 mg | [1] Prednisone acetate Prednisone acetate | [1] Prednisone acetate
Prednisone acetate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬 |
1106 | Cortecosteroid | - | - | - | - | [1] 96 96 💬 |
1107 | Cortef | [2] Hydrocortisone Hydrocortisone, Hydrocortisone cypionate | [2] Hydrocortisone
Hydrocortisone
,
Hydrocortisone cypionate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 6 6, 81, 83 💬 |
1108 | Cortef (hydrocortisone) | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 83 83 💬 |
1109 | Cortef 5 mg | [1] Hydrocortisone cypionate Hydrocortisone cypionate | [1] Hydrocortisone cypionate
Hydrocortisone cypionate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 83 83 💬 |
1110 | Corticoids+ tocilizumab 8mg/Kg/4 weeks | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬 |
1111 | Corticosteroid | - | - | - | - | [9] 13 13, 42, 43, 44, 45, 66, 96, 97, 222 💬 |
1112 | Corticosteroid (CS) | - | - | - | - | [1] 41 41 💬 |
1113 | Corticosteroid and azathioprine | [1] Azathioprine Azathioprine | [1] Azathioprine
Azathioprine
💬 | - | - | [4] 42 42, 43, 44, 45 💬 |
1114 | Corticosteroid and non-biological agents. | - | - | - | - | [1] 46 46 💬 |
1115 | Corticosteroid or NSAID | - | - | - | - | [1] 46 46 💬 |
1116 | Corticosteroid treatment (Methylprednisolone or prednisolone) | [2] Methylprednisolone Methylprednisolone, Prednisolone | [2] Methylprednisolone
Methylprednisolone
,
Prednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 64 64 💬 |
1117 | Corticosteroids | - | - | - | - | [12] 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬 |
1118 | Corticosteroids & tanCART19/20 | - | - | - | - | [1] 13 13 💬 |
1119 | Corticosteroids (Aprednislon) | - | - | - | - | [1] 63 63 💬 |
1120 | Corticosteroids (prednisone or prednisolone) | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬 |
1121 | Corticosteroids +immune suppressive +amino salicylic acid | [1] Salicylic acid Salicylic acid | [1] Salicylic acid
Salicylic acid
💬 | - | - | [1] 97 97 💬 |
1122 | Corticosteroids for Systemic Use | - | - | - | - | [1] 41 41 💬 |
1123 | Corticosteroids only | - | - | - | - | [1] 97 97 💬 |
1124 | Corticosteroids'therapy | - | - | - | - | [1] 35 35 💬 |
1125 | Corticotherapy | - | - | - | - | [1] 66 66 💬 |
1126 | Corticotrophin | [1] Corticotropin Corticotropin | [1] Corticotropin
Corticotropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 46 46 💬 |
1127 | Corticotrophin 80 units | [1] Corticotropin Corticotropin | [1] Corticotropin
Corticotropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 46 46 💬 |
1128 | Corticotropin | [1] Corticotropin Corticotropin | [1] Corticotropin
Corticotropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [7] 2 2, 13, 46, 75, 81, 84, 222 💬 |
1129 | Corticotropin-releasing hormone | [2] Corticorelin Corticorelin, Corticotropin | [2] Corticotropin
Corticotropin
,
Corticorelin
💬 | [3] CRHR1 CRHR1, CRHR2, MC2R 💬 | [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 💬 |
1130 | CortimentMMX 9 mg | - | - | - | - | [1] 97 97 💬 |
1131 | Cortisol | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬 |
1132 | Cortison | - | - | - | - | [1] 81 81 💬 |
1133 | Cortisone | [2] Cortisone Cortisone, Hydrocortisone | [2] Hydrocortisone
Hydrocortisone
,
Cortisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬 |
1134 | Cortisone acetate | [4] Acetate Acetate, Cortisone, Cortisone acetate, Hydrocortisone | [3] Hydrocortisone
Hydrocortisone
,
Cortisone acetate
,
Cortisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬 |
1135 | Corynebacterium diphtheriae | [1] Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | [1] 11 11 💬 |
1136 | Cosentyx | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [4] 41 41, 107, 269, 271 💬 |
1137 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 1 SIRINGA PRERIEMPITA | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 107 107 💬 |
1138 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 2 SIRINGHE PRERIEMPITE | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 107 107 💬 |
1139 | Cosentyx 300 mg solution for injection in pre-filled syringe | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬 |
1140 | Cosentyx 300mg solution for injection in pre-filled syringe | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬 |
1141 | Cosentyx® | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 269 269 💬 |
1142 | Cosintropina acetato | - | - | - | - | [1] 113 113 💬 |
1143 | CosmoFer | - | - | - | - | [3] 86 86, 96, 97 💬 |
1144 | CosmoFer 50mg/ml solution for infusion or injection | - | - | - | - | [2] 96 96, 97 💬 |
1145 | Costicosteroids | - | - | - | - | [1] 26 26 💬 |
1146 | Cosyntropin | [1] Tetracosactide Tetracosactide | [1] Cosyntropin
Cosyntropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 113 113, 145 💬 |
1147 | Cosyntropin acetate | [2] Acetate Acetate, Tetracosactide | [1] Cosyntropin
Cosyntropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 113 113 💬 |
1148 | Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin | [2] Tetracosactide Tetracosactide, Vigabatrin | [2] Cosyntropin
Cosyntropin
,
Vigabatrin
💬 | [2] ABAT ABAT, MC2R 💬 | [12] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬 | [1] 145 145 💬 |
1149 | Cosyntropin Injectable Suspension, 1 mg/mL | [1] Tetracosactide Tetracosactide | [1] Cosyntropin
Cosyntropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 145 145 💬 |
1150 | Cotoretigene Toliparvovec | [1] Cotoretigene toliparvovec Cotoretigene toliparvovec | - | - | - | [1] 90 90 💬 |
1151 | Cotrimoxazole | - | - | - | - | [2] 85 85, 97 💬 |
1152 | COVERSIN | [1] Nomacopan Nomacopan | [1] Nomacopan
Nomacopan
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2] 62 62, 109 💬 |
1153 | Coversyl | [1] Perindopril Perindopril | [1] Perindopril
Perindopril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [2] 19 19, 167 💬 |
1154 | Coversyl (perindopril) | [1] Perindopril Perindopril | [1] Perindopril
Perindopril
💬 | [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 167 167 💬 |
1155 | Coversyl PLUS | - | - | - | - | [1] 19 19 💬 |
1156 | COVID-19 mRNA Vaccine (nucleoside modified) | - | - | - | - | [3] 13 13, 46, 51 💬 |
1157 | COVID-19 mRNA vaccine (nucleoside-modified) | - | - | - | - | [4] 13 13, 46, 51, 299 💬 |
1158 | COVID-19 mRNA vaccine Moderna (CX-024414) | - | - | - | - | [4] 13 13, 46, 51, 299 💬 |
1159 | COVID-19 vaccination | - | - | - | - | [1] 13 13 💬 |
1160 | COVID-19 vaccine | - | - | - | - | [3] 46 46, 49, 51 💬 |
1161 | COVID-19 vaccine (Ad26.COV2-S [recombinant]) | - | - | - | - | [1] 299 299 💬 |
1162 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | - | - | - | - | [3] 46 46, 51, 299 💬 |
1163 | COVID-19 Vaccine AstraZeneca | [1] AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | [3] 46 46, 51, 53 💬 |
1164 | COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19) | [1] AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | [3] 46 46, 51, 299 💬 |
1165 | COVID-19 Vaccine AstraZeneca suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant]) | [1] AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | [1] 53 53 💬 |
1166 | Covid-19 Vaccine Janssen | [1] Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | [1] COVID-19 vaccine
COVID-19 vaccine
💬 | - | - | [2] 53 53, 299 💬 |
1167 | COVID-19 Vaccine Janssen suspension for injection | [1] Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | [1] COVID-19 vaccine
COVID-19 vaccine
💬 | - | - | [1] 299 299 💬 |
1168 | COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant]) | [1] Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | [1] COVID-19 vaccine
COVID-19 vaccine
💬 | - | - | [2] 53 53, 299 💬 |
1169 | COVID-19 Vaccine Moderna | [1] Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | [1] Elasomeran
Elasomeran
💬 | - | - | [4] 46 46, 51, 65, 299 💬 |
1170 | COVID-19 Vaccine Moderna dispersion for injection | [1] Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | [1] Elasomeran
Elasomeran
💬 | - | - | [1] 299 299 💬 |
1171 | COVID19 vaccine | - | - | - | - | [1] 13 13 💬 |
1172 | Cozaar | [1] Losartan Losartan | [1] Losartan
Losartan
💬 | [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 167 167 💬 |
1173 | Cozaar 50 | [1] Losartan Losartan | [1] Losartan
Losartan
💬 | [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 167 167 💬 |
1174 | COZAAR 50 mg comprimidos recubierto con pelicula | [1] Losartan Losartan | [1] Losartan
Losartan
💬 | [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 179 179 💬 |
1175 | COZAAR INICIO 12,5 mg comprimidos recubiertos con pelicula | [1] Losartan Losartan | [1] Losartan
Losartan
💬 | [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 167 167 💬 |
1176 | CP | - | - | - | - | [6] 6 6, 46, 96, 97, 107, 271 💬 |
1177 | CP 690,550 | - | - | - | - | [1] 46 46 💬 |
1178 | CP 690550 MR | - | - | - | - | [1] 46 46 💬 |
1179 | CP- 690 550 | - | - | - | - | [1] 97 97 💬 |
1180 | CP-195,543 | - | - | - | - | [1] 46 46 💬 |
1181 | CP-461 | - | - | - | - | [1] 96 96 💬 |
1182 | CP-690, 550 - 10 | - | - | - | - | [1] 46 46 💬 |
1183 | CP-690, 550-10 | - | - | - | - | [2] 97 97, 107 💬 |
1184 | CP-690,500 5 mg | - | - | - | - | [1] 97 97 💬 |
1185 | CP-690,55-10 | - | - | - | - | [1] 46 46 💬 |
1186 | CP-690,550 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬 |
1187 | CP-690,550 (tasocitinib) | [1] Tofacitinib Tofacitinib | [1] Tofacitinib
Tofacitinib
💬 | [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 💬 |
1188 | CP-690,550 (tofacitinib) | [1] Tofacitinib Tofacitinib | [1] Tofacitinib
Tofacitinib
💬 | [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 107 💬 |
1189 | CP-690,550 + methotrexate | [1] Methotrexate Methotrexate | [1] Methotrexate
Methotrexate
💬 | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 💬 |
1190 | CP-690,550 10 mg | - | - | - | - | [1] 97 97 💬 |
1191 | CP-690,550 – 10 | - | - | - | - | [1] 46 46 💬 |
1192 | CP-690,550-10 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬 |
1193 | CP-690-550 | - | - | - | - | [1] 46 46 💬 |
1194 | CP-690-550-10 | - | - | - | - | [1] 107 107 💬 |
1195 | CP-690-550-10 (DMID D1600180) | - | - | - | - | [1] 107 107 💬 |
1196 | CP690,550 | - | - | - | - | [2] 46 46, 97 💬 |
1197 | CPHC (carboxy pyrrolidine hexanoyl pyrrolidone carboxylate) | [1] Pyrrolidine Pyrrolidine | - | - | - | [1] 28 28 💬 |
1198 | CPK850 | - | - | - | - | [1] 90 90 💬 |
1199 | CPL409116 | - | - | - | - | [1] 46 46 💬 |
1200 | CPL500036 | - | - | - | - | [1] 6 6 💬 |
1201 | CPL500036 - high dose | - | - | - | - | [1] 6 6 💬 |
1202 | CPL500036 - low dose | - | - | - | - | [1] 6 6 💬 |
1203 | CPP | - | - | - | - | [1] 76 76 💬 |
1204 | CPSI-2364 | - | - | - | - | [1] 96 96 💬 |
1205 | CPX | - | - | - | - | [1] 299 299 💬 |
1206 | CR 1 | - | - | - | - | [1] 46 46 💬 |
1207 | CR 2 | - | - | - | - | [1] 46 46 💬 |
1208 | CR 3 | - | - | - | - | [1] 46 46 💬 |
1209 | CR002 | [1] CR002 CR002 | - | - | - | [1] 299 299 💬 |
1210 | CR002 Liquid API | [1] CR002 CR002 | - | - | - | [1] 299 299 💬 |
1211 | CR0686 | - | - | - | - | [1] 46 46 💬 |
1212 | Cr13C | - | - | - | - | [1] 113 113 💬 |
1213 | CR6086 | [1] CR6086 CR6086 | - | - | - | [1] 46 46 💬 |
1214 | CR6086Z | - | - | - | - | [1] 46 46 💬 |
1215 | CR845 1.0 mg | - | - | - | - | [1] 93 93 💬 |
1216 | Cranberry | [1] Cranberry Cranberry | - | - | - | [1] 13 13 💬 |
1217 | Cravit | - | - | - | - | [1] 85 85 💬 |
1218 | CRC (A3384) | - | - | - | - | [3] 93 93, 297, 338 💬 |
1219 | CRC3357, ZK-355322, Leukoton | - | - | - | - | [1] 299 299 💬 |
1220 | CRD-TMH-001 | - | - | - | - | [1] 113 113 💬 |
1221 | CRD007 | - | - | - | - | [1] 113 113 💬 |
1222 | Creapure | - | - | - | - | [1] 50 50 💬 |
1223 | Creatine | [1] Creatine Creatine | - | - | - | [11] 1 1, 2, 5, 6, 8, 46, 49, 50, 113, 156, 201 💬 |
1224 | Creatine Monohydrate | [1] Creatine Creatine | - | - | - | [4] 2 2, 8, 113, 156 💬 |
1225 | Creatine-13C | [1] Creatine Creatine | - | - | - | [1] 113 113 💬 |
1226 | Creatinine | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬 | - | - | [5] 2 2, 46, 60, 70, 222 💬 |
1227 | Crema de rapamicina al 1% y excipientes | - | - | - | - | [1] 157 157 💬 |
1228 | Crema placebo (excipiente) | - | - | - | - | [1] 157 157 💬 |
1229 | CREON | - | - | - | - | [2] 298 298, 299 💬 |
1230 | Creon 10.000, hårde enterokapsler | - | - | - | - | [1] 299 299 💬 |
1231 | Creon 10000 | - | - | - | - | [2] 298 298, 299 💬 |
1232 | CREON 10000 Capsules | - | - | - | - | [1] 299 299 💬 |
1233 | Creon 25.000, hårde enterokapsler | - | - | - | - | [1] 299 299 💬 |
1234 | Creon 25000 | - | - | - | - | [2] 298 298, 299 💬 |
1235 | Creon 40.000, hårde enterokapsler | - | - | - | - | [1] 299 299 💬 |
1236 | CREON IR | - | - | - | - | [1] 299 299 💬 |
1237 | Creon N | - | - | - | - | [1] 299 299 💬 |
1238 | CREON N 25000 | - | - | - | - | [1] 299 299 💬 |
1239 | Creon36™ | - | - | - | - | [1] 298 298 💬 |
1240 | Creon® | - | - | - | - | [1] 299 299 💬 |
1241 | Creon® (DR/GR) | - | - | - | - | [1] 299 299 💬 |
1242 | Creon® 25,000 | - | - | - | - | [1] 299 299 💬 |
1243 | Crestor | [1] Rosuvastatin Rosuvastatin | [1] Rosuvastatin
Rosuvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3] 49 49, 79, 299 💬 |
1244 | Crestor Film-Coated Tablet | [1] Rosuvastatin Rosuvastatin | [1] Rosuvastatin
Rosuvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬 |
1245 | Crestor Tablets (calcium rosuvastatin) Film-Coated tablets | [2] Calcium Calcium, Rosuvastatin | [1] Rosuvastatin
Rosuvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬 |
1246 | CRH | - | - | - | - | [1] 310 310 💬 |
1247 | Crinecerfont | - | - | - | - | [1] 81 81 💬 |
1248 | Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist. | [1] Corticotropin Corticotropin | [1] Corticotropin
Corticotropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 81 81 💬 |
1249 | Crizotinib | [1] Crizotinib Crizotinib | [1] Crizotinib
Crizotinib
💬 | [1] ALK ALK 💬 | [3] Non-small cell lung cancer Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬 | [1] 34 34 💬 |
1250 | CRM197 | [1] Corynebacterium diphtheriae CRM197 protein Corynebacterium diphtheriae CRM197 protein | - | - | - | [3] 11 11, 13, 46 💬 |
1251 | Crocin | [1] Crocin Crocin | - | - | - | [1] 6 6 💬 |
1252 | Crocin and Apigenin | [2] Apigenin Apigenin, Crocin | - | - | - | [1] 6 6 💬 |
1253 | Crohn's Disease | - | - | - | - | [1] 96 96 💬 |
1254 | Crohn's disease exclusion diet (CDED) | - | - | - | - | [1] 96 96 💬 |
1255 | Crohns Disease Exclusion Diet + PEN | - | - | - | - | [1] 96 96 💬 |
1256 | Cromoglicate | [1] Cromoglicic acid Cromoglicic acid | [1] Cromoglicic acid
Cromoglicic acid
💬 | - | - | [1] 85 85 💬 |
1257 | Cromoglicato disodico | - | - | - | - | [1] 85 85 💬 |
1258 | Cromoglycate | [1] Cromoglicic acid Cromoglicic acid | [1] Cromoglicic acid
Cromoglicic acid
💬 | - | - | [1] 85 85 💬 |
1259 | Cromolyn | [1] Cromoglicic acid Cromoglicic acid | [1] Cromoglicic acid
Cromoglicic acid
💬 | - | - | [3] 2 2, 85, 98 💬 |
1260 | Cromolyn sodio (cromoglicato disodico, DSCG) | [1] Cromoglicic acid Cromoglicic acid | [1] Cromoglicic acid
Cromoglicic acid
💬 | - | - | [1] 85 85 💬 |
1261 | Cromolyn Sodium | [1] Cromoglicic acid Cromoglicic acid | [1] Cromoglicic acid
Cromoglicic acid
💬 | - | - | [1] 85 85 💬 |
1262 | Cromolyn sodium [Disodium Cromoglycate] | [1] Cromoglicic acid Cromoglicic acid | [1] Cromoglicic acid
Cromoglicic acid
💬 | - | - | [1] 85 85 💬 |
1263 | CROVALIMAB | [1] Crovalimab Crovalimab | [1] Crovalimab
Crovalimab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2] 62 62, 109 💬 |
1264 | CROWN | - | - | - | - | [1] 96 96 💬 |
1265 | CRx-102 | - | - | - | - | [1] 46 46 💬 |
1266 | CRx-102 (2.7/180) | - | - | - | - | [1] 46 46 💬 |
1267 | CRx-102 (2.7/360) | - | - | - | - | [1] 46 46 💬 |
1268 | CRX-139 | [1] CRx-139 CRx-139 | - | - | - | [1] 46 46 💬 |
1269 | CRx-150 | - | - | - | - | [1] 46 46 💬 |
1270 | CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE | - | - | - | - | [1] 19 19 💬 |
1271 | Cryopreserved EFS-ADA LV transduced patient CD34+ cells | - | - | - | - | [1] 65 65 💬 |
1272 | Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells | - | - | - | - | [1] 65 65 💬 |
1273 | Cryostor CS10 | - | - | - | - | [1] 53 53 💬 |
1274 | Cryosupernatant plasma | - | - | - | - | [1] 64 64 💬 |
1275 | Crystalline calcium supplements | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | [1] 235 235 💬 |
1276 | Crystalline cholesterol oil-based suspension | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬 | - | - | [1] 310 310 💬 |
1277 | Crysvita (burosumab-twza) Treatment | [1] Burosumab Burosumab | [1] Burosumab
Burosumab
💬 | [1] FGF23 FGF23 💬 | [11] Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | [1] 238 238 💬 |
1278 | CS (corticosteroids) Only | - | - | - | - | [1] 97 97 💬 |
1279 | CS-0777 tablets | - | - | - | - | [1] 13 13 💬 |
1280 | CS0159 | - | - | - | - | [2] 93 93, 94 💬 |
1281 | CS1 Administration | - | - | - | - | [1] 86 86 💬 |
1282 | CS10BR05 | - | - | - | - | [1] 17 17 💬 |
1283 | CS20AT04 (allogenic bone marrow derived mesenchymal stem cell) | - | - | - | - | [1] 49 49 💬 |
1284 | CsA | - | - | - | - | [8] 19 19, 49, 50, 53, 60, 63, 222, 228 💬 |
1285 | CSCC_ASC(22) | - | - | - | - | [1] 53 53 💬 |
1286 | CsDMARD(s) | - | - | - | - | [1] 46 46 💬 |
1287 | CsDMARDs | - | - | - | - | [1] 46 46 💬 |
1288 | CSF sampling | - | - | - | - | [1] 13 13 💬 |
1289 | CSL312 | - | - | - | - | [1] 85 85 💬 |
1290 | CSL312 Garadacimab | [1] Garadacimab Garadacimab | - | - | - | [1] 85 85 💬 |
1291 | CSL787 | - | - | - | - | [1] 299 299 💬 |
1292 | CSM allogéniques issues de cordons ombilicaux ( MTI-PP) | - | - | - | - | [1] 49 49 💬 |
1293 | CSs | - | - | - | - | [1] 107 107 💬 |
1294 | CST-103 | - | - | - | - | [1] 6 6 💬 |
1295 | CST-107 | - | - | - | - | [1] 6 6 💬 |
1296 | CST-139 | - | - | - | - | [1] 6 6 💬 |
1297 | CSTI-500 | - | - | - | - | [1] 193 193 💬 |
1298 | CT- P10 | - | - | - | - | [1] 46 46 💬 |
1299 | CT-G20 | - | - | - | - | [1] 58 58 💬 |
1300 | CT-P10 | - | - | - | - | [1] 46 46 💬 |
1301 | CT-P13 | - | - | - | - | [4] 46 46, 96, 97, 271 💬 |
1302 | CT-P13 SC (Infliximab) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬 |
1303 | CT-P17 | - | - | - | - | [1] 46 46 💬 |
1304 | CT-P17 SC | - | - | - | - | [1] 46 46 💬 |
1305 | CT-P17 SC AI (adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
1306 | CT-P47 AI (tocilizumab) | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬 |
1307 | CT-P47 PFS (tocilizumab) | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬 |
1308 | CT103A cells | - | - | - | - | [2] 11 11, 13 💬 |
1309 | CTI-1601 | [1] CTI-1601 CTI-1601 | - | - | - | [1] 18 18 💬 |
1310 | CTLA4-IgG4m (RG2077) | - | - | - | - | [1] 49 49 💬 |
1311 | CTLA4Ig | - | - | - | - | [4] 46 46, 49, 96, 271 💬 |
1312 | CTNS-RD-04 or CTNS-RD-04-LB (where the suffix -LB stands for LentiBOOST) | - | - | - | - | [1] 19 19 💬 |
1313 | CTX-4430 | - | - | - | - | [1] 299 299 💬 |
1314 | Cu(II)ATSM | - | - | - | - | [2] 2 2, 6 💬 |
1315 | Cu-64 DOTATATE | [1] Dotatate Dotatate | - | - | - | [1] 84 84 💬 |
1316 | Cudetaxestat (BLD-0409) | - | - | - | - | [1] 85 85 💬 |
1317 | Cufence | [1] Triethylenetetramine Triethylenetetramine | - | - | - | [2] 58 58, 171 💬 |
1318 | Cufence (trientine dihydrochloride) | [1] Triethylenetetramine Triethylenetetramine | - | - | - | [1] 171 171 💬 |
1319 | CUG252 | - | - | - | - | [1] 49 49 💬 |
1320 | Cultivated oral mucosal epithelial sheet transplantation | - | - | - | - | [2] 38 38, 162 💬 |
1321 | Cultured allogeneic fibroblasts | - | - | - | - | [1] 36 36 💬 |
1322 | Cultured Thymus Tissue | - | - | - | - | [1] 65 65 💬 |
1323 | Cultured Thymus Tissue for Implantation (CTTI) | - | - | - | - | [1] 65 65 💬 |
1324 | Cultured Thymus Tissue Implantation (CTTI) | - | - | - | - | [1] 65 65 💬 |
1325 | Cumulative corticosteroid exposure | - | - | - | - | [1] 49 49 💬 |
1326 | Cuprimine (penicillamine) | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬 | - | - | [1] 51 51 💬 |
1327 | Cuprior | [1] Triethylenetetramine Triethylenetetramine | - | - | - | [1] 171 171 💬 |
1328 | Cuprior 150 mg | [1] Triethylenetetramine Triethylenetetramine | - | - | - | [1] 171 171 💬 |
1329 | Cuprior 150 mg film-coated tablets | [1] Triethylenetetramine Triethylenetetramine | - | - | - | [1] 171 171 💬 |
1330 | Cuprior 150mg film-coated tablets | [1] Triethylenetetramine Triethylenetetramine | - | - | - | [1] 171 171 💬 |
1331 | Cura-100 | - | - | - | - | [1] 46 46 💬 |
1332 | Curcuma | - | - | - | - | [1] 96 96 💬 |
1333 | Curcuma Longa | [1] Turmeric Turmeric | - | - | - | [2] 96 96, 299 💬 |
1334 | Curcuma Longa Extract | [1] Turmeric Turmeric | - | - | - | [1] 299 299 💬 |
1335 | Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg | [1] Turmeric Turmeric | - | - | - | [1] 299 299 💬 |
1336 | CURCUMA LONGA RHIZOMA | [1] Turmeric Turmeric | - | - | - | [1] 96 96 💬 |
1337 | Curcumin | [1] Curcumin Curcumin | - | - | - | [10] 2 2, 13, 46, 67, 74, 94, 96, 97, 139, 299 💬 |
1338 | Curcumin (Longvida™) | [1] Curcumin Curcumin | - | - | - | [1] 46 46 💬 |
1339 | Curcumin Supplementation | [1] Curcumin Curcumin | - | - | - | [1] 97 97 💬 |
1340 | Curosurf | [1] Poractant alfa Poractant alfa | [1] Poractant alfa
Poractant alfa
💬 | - | - | [1] 211 211 💬 |
1341 | Current lipid-lowering treatment | - | - | - | - | [1] 79 79 💬 |
1342 | Current marketed FLOLAN (epoprostenol sodium) | [1] Epoprostenol Epoprostenol | [1] Epoprostenol
Epoprostenol
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬 |
1343 | Current treatment of AL-CM | - | - | - | - | [1] 28 28 💬 |
1344 | Currently available therapy in the community | - | - | - | - | [1] 51 51 💬 |
1345 | Cushing's syndrome confirmation | - | - | - | - | [1] 75 75 💬 |
1346 | Cutaneous iontophoresis of treprostinil | [1] Treprostinil Treprostinil | [1] Treprostinil
Treprostinil
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬 |
1347 | CUTAQUIG | - | - | - | - | [1] 65 65 💬 |
1348 | CUV1647 | - | - | - | - | [1] 254 254 💬 |
1349 | CUVITRU | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 💬 |
1350 | Cuvitru 200 mg/ml solution for subcutaneous injection | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 💬 |
1351 | CV-MG01 | [1] CV-MG01 CV-MG01 | - | - | - | [1] 11 11 💬 |
1352 | CVD00118-E | - | - | - | - | [1] 6 6 💬 |
1353 | CVL-751 | - | - | - | - | [1] 6 6 💬 |
1354 | CVN424 | - | - | - | - | [1] 6 6 💬 |
1355 | CVT-301 | - | - | - | - | [1] 6 6 💬 |
1356 | CVT-301 (Dose Level 1) | - | - | - | - | [1] 6 6 💬 |
1357 | CVT-301 (Dose Level 2) | - | - | - | - | [1] 6 6 💬 |
1358 | CVT-301 35mg | - | - | - | - | [1] 6 6 💬 |
1359 | CVT-301 50mg | - | - | - | - | [1] 6 6 💬 |
1360 | CVT-301 High Dose | - | - | - | - | [1] 6 6 💬 |
1361 | CVT-301 Low Dose | - | - | - | - | [1] 6 6 💬 |
1362 | CVT-301, LIP | - | - | - | - | [1] 6 6 💬 |
1363 | CVXL-0107 | - | - | - | - | [1] 6 6 💬 |
1364 | CX-016492 | - | - | - | - | [1] 245 245 💬 |
1365 | CX-017950 | - | - | - | - | [1] 245 245 💬 |
1366 | CX-4945 oral formulation | - | - | - | - | [1] 331 331 💬 |
1367 | CX-8998 | - | - | - | - | [1] 6 6 💬 |
1368 | Cx401 | - | - | - | - | [1] 96 96 💬 |
1369 | CX501 | [1] CX501 CX501 | - | - | - | [1] 36 36 💬 |
1370 | CX516 | [1] CX516 CX516 | - | - | - | [1] 206 206 💬 |
1371 | CX516 (Ampalex®) | [1] CX516 CX516 | - | - | - | [1] 206 206 💬 |
1372 | Cx601 | - | - | - | - | [1] 96 96 💬 |
1373 | CXA-10 | [1] CXA-10 CXA-10 | - | - | - | [2] 86 86, 222 💬 |
1374 | Cy | - | - | - | - | [1] 60 60 💬 |
1375 | Cy-ATG | - | - | - | - | [1] 60 60 💬 |
1376 | CyA | - | - | - | - | [2] 50 50, 222 💬 |
1377 | CyberKnife | - | - | - | - | [1] 6 6 💬 |
1378 | CYC | - | - | - | - | [1] 40 40 💬 |
1379 | CYC202 | - | - | - | - | [1] 299 299 💬 |
1380 | Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly di-aspartate | - | - | - | - | [1] 75 75 💬 |
1381 | Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly di-aspartate | - | - | - | - | [1] 75 75 💬 |
1382 | Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) di-aspartate | - | - | - | - | [1] 75 75 💬 |
1383 | Cyclo(diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) | - | - | - | - | [1] 75 75 💬 |
1384 | CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL] | - | - | - | - | [1] 299 299 💬 |
1385 | Cyclophosfamide | - | - | - | - | [1] 13 13 💬 |
1386 | Cyclophosphamid | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 66 66 💬 |
1387 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬 |
1388 | Cyclophosphamide (CY) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 60 60 💬 |
1389 | Cyclophosphamide (CY) (Plan 1) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [2] 60 60, 285 💬 |
1390 | Cyclophosphamide (CY) (Plan 2) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [2] 60 60, 285 💬 |
1391 | Cyclophosphamide (Cytoxan) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 65 65 💬 |
1392 | Cyclophosphamide (drug) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 13 13 💬 |
1393 | Cyclophosphamide + pred | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 283 283 💬 |
1394 | Cyclophosphamide 100mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 60 60 💬 |
1395 | Cyclophosphamide 150mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 60 60 💬 |
1396 | Cyclophosphamide 30 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [3] 65 65, 285, 326 💬 |
1397 | Cyclophosphamide 40 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [3] 65 65, 285, 326 💬 |
1398 | Cyclophosphamide 50mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 60 60 💬 |
1399 | Cyclophosphamide 50Mg Oral Tablet | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 162 162 💬 |
1400 | Cyclophosphamide and ATG | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 13 13 💬 |
1401 | Cyclophosphamide and fludarabine | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 11 11, 13 💬 |
1402 | Cyclophosphamide and steroids | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 222 222 💬 |
1403 | Cyclophosphamide Dose Level 1 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [2] 65 65, 284 💬 |
1404 | Cyclophosphamide Dose Level 2 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [2] 65 65, 284 💬 |
1405 | Cyclophosphamide Dose Level 3 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [2] 65 65, 284 💬 |
1406 | Cyclophosphamide Dose Level 4 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [2] 65 65, 284 💬 |
1407 | Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids | [3] Azathioprine Azathioprine, Cyclophosphamide, Methotrexate | [4] Methotrexate
Methotrexate
,
Azathioprine
,
Cyclophosphamide
,
Cyclophosphamide
💬 | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 44 44 💬 |
1408 | Cyclophosphamide Injection 1g | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [3] 50 50, 51, 52 💬 |
1409 | CYCLOPHOSPHAMIDE MONOHYDRATE | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [4] 13 13, 60, 96, 256 💬 |
1410 | Cyclophosphamide post transplant | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 65 65 💬 |
1411 | Cyclophosphamide(CTX) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 224 224 💬 |
1412 | Cyclophosphamide, Azathioprine,prednisone,methylprednisolone | [4] Azathioprine Azathioprine, Cyclophosphamide, Methylprednisolone, Prednisone | [5] Azathioprine
Azathioprine
,
Cyclophosphamide
,
Methylprednisolone
,
Prednisone
,
Cyclophosphamide
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 💬 |
1413 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [4] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
,
Cyclophosphamide
💬 | [2] NR3C1 NR3C1, PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬 |
1414 | Cyclophosphamide, Bortezomib, dexamethasone | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [4] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
,
Cyclophosphamide
💬 | [2] NR3C1 NR3C1, PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬 |
1415 | Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab | [4] Bortezomib Bortezomib, Cyclophosphamide, Daratumumab, Dexamethasone | [5] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
,
Cyclophosphamide
,
Daratumumab
💬 | [3] CD38 CD38, NR3C1, PSMB5 💬 | [16] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | [1] 28 28 💬 |
1416 | Cyclophosphamide, fludarabine , thymoglobulin | [3] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬 |
1417 | Cyclophosphamide, Fludarabine, Rabbit ATG | [4] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclophosphamide, Fludarabine, Rabbit | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬 |
1418 | Cyclophosphamide, Fludarabine, Thymoglobulin | [3] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬 |
1419 | Cyclophosphamide,Campath IH and TBI | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 60 60 💬 |
1420 | Cyclophosphamide,cyclosporine A | [2] Cyclophosphamide Cyclophosphamide, Cyclosporine | [3] Cyclosporine
Cyclosporine
,
Cyclophosphamide
,
Cyclophosphamide
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬 |
1421 | Cyclophosphamide-prednisone-azathioprine | [3] Azathioprine Azathioprine, Cyclophosphamide, Prednisone | [4] Azathioprine
Azathioprine
,
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬 |
1422 | Cyclophosphamide/ATG | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 13 13 💬 |
1423 | Cyclophosphamide/Glatiramer acetate | [3] Acetate Acetate, Cyclophosphamide, Glatiramer | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 13 13 💬 |
1424 | Cyclophosphamide/Rituximab | [2] Cyclophosphamide Cyclophosphamide, Rituximab | [3] Cyclophosphamide
Cyclophosphamide
,
Rituximab
,
Cyclophosphamide
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬 |
1425 | Cyclophosphamidum | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 44 44 💬 |
1426 | Cyclophosphamidum 500 mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [1] 44 44 💬 |
1427 | Cyclosphamine | - | - | - | - | [1] 85 85 💬 |
1428 | Cyclosporin | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [17] 38 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
1429 | Cyclosporin A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 46 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 |
1430 | Cyclosporin A+Glucocorticoids | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 60 60, 62 💬 |
1431 | Cyclosporin, low dose steroid | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬 |
1432 | Cyclosporin, Methotrexate (GVHD prophylaxis) | [2] Cyclosporine Cyclosporine, Methotrexate | [2] Methotrexate
Methotrexate
,
Cyclosporine
💬 | [7] DHFR DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [38] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 326 326 💬 |
1433 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
1434 | Cyclosporine (Gengraf ) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬 |
1435 | Cyclosporine (USAN) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬 |
1436 | Cyclosporine 0.09% Ophthalmic Solution | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 53 53 💬 |
1437 | Cyclosporine 5 mg/kg bid days 0-14 | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 38 38, 39 💬 |
1438 | Cyclosporine A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 19 19, 20, 36, 49, 50, 53, 58, 60, 107, 234, 283 💬 |
1439 | Cyclosporine A (CsA) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 19 19, 60 💬 |
1440 | Cyclosporine A dry powder inhalation (Drug) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
1441 | Cyclosporine combine with mycophenolate mofetil | [3] Cyclosporine Cyclosporine, Mycophenolate mofetil, Mycophenolic acid | [3] Cyclosporine
Cyclosporine
,
Mycophenolate mofetil
,
Mycophenolic acid
💬 | [7] IMPDH1 IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [37] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 283 283 💬 |
1442 | Cyclosporine Inhalation Solution | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
1443 | Cyclosporine Inhalation Solution (CIS) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬 |
1444 | Cyclosporine Oral Product | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬 |
1445 | Cyclosporine Pill | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 56 56 💬 |
1446 | CYCLOSPORINE VS INFLIXIMAB | [2] Cyclosporine Cyclosporine, Infliximab | [2] Cyclosporine
Cyclosporine
,
Infliximab
💬 | [6] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF 💬 | [86] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 97 97 💬 |
1447 | Cyclosporine-A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 95 95 💬 |
1448 | Cyclosporins | - | - | - | - | [4] 53 53, 60, 65, 222 💬 |
1449 | CyCol | - | - | - | - | [1] 97 97 💬 |
1450 | CyCol™ | - | - | - | - | [1] 97 97 💬 |
1451 | Cyklokapron® | - | - | - | - | [1] 46 46 💬 |
1452 | Cyltezo | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬 |
1453 | CYMBALTA | [1] Duloxetine Duloxetine | [1] Duloxetine
Duloxetine
💬 | [2] SLC6A2 SLC6A2, SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [3] 6 6, 13, 49 💬 |
1454 | CYP substrates | - | - | - | - | [1] 98 98 💬 |
1455 | Cystadane | [1] Betaine Betaine | [1] Betaine
Betaine
💬 | - | - | [1] 19 19 💬 |
1456 | Cystadane anhydrous | [1] Betaine Betaine | [1] Betaine
Betaine
💬 | - | - | [1] 19 19 💬 |
1457 | CYSTADROPS | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1458 | CYSTADROPS 0.55% eye drops, solution | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1459 | CYSTAGON | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [3] 8 8, 19, 299 💬 |
1460 | Cystagon (cysteamine bitartrate) immediate-release capsules | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 299 299 💬 |
1461 | Cystagon 150mg | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1462 | Cystagon 50mg | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1463 | Cystagon® | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1464 | Cystagon® (Cysteamine Bitartrate) | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1465 | Cysteamine | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [4] 8 8, 19, 21, 299 💬 |
1466 | Cysteamine (mercaptamine) viscous solution | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1467 | Cysteamine Bitartrate | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [4] 8 8, 19, 21, 299 💬 |
1468 | Cysteamine bitartrate (Cystagon) | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 299 299 💬 |
1469 | Cysteamine bitartrate (INN: mercaptamine bitartrate | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1470 | Cysteamine bitartrate (INN: mercaptamine bitartrate ) | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1471 | Cysteamine bitartrate (INN: mercaptamine bitartrate) | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1472 | Cysteamine Bitartrate Delayed-release Capsules | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1473 | Cysteamine Bitartrate Delayed-release Capsules (RP103) | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1474 | CYSTEAMINE HYDROCHLORIDE | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
1475 | Cysteine | [1] Cysteine Cysteine | - | - | - | [10] 13 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
1476 | Cysteine hydrochloride | [1] Cysteine Cysteine | - | - | - | [1] 254 254 💬 |
1477 | Cystic Fibrosis Ready to Use Supplemental Food | - | - | - | - | [1] 299 299 💬 |
1478 | Cystic fibrosis transmembrane conductance regulator | - | - | - | - | [1] 299 299 💬 |
1479 | Cystoscopic injection of Botox into the urinary bladder | [1] Botulinum toxin type A Botulinum toxin type A | [1] Botulinum toxin type A
Botulinum toxin type A
💬 | [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 6 6 💬 |
1480 | CYT107 | - | - | - | - | [1] 25 25 💬 |
1481 | Cytarabine | [1] Cytarabine Cytarabine | [1] Cytarabine
Cytarabine
💬 | - | - | [7] 11 11, 13, 14, 25, 49, 60, 65 💬 |
1482 | Cytochrome P450 (CYP) Substrates | - | - | - | - | [2] 96 96, 97 💬 |
1483 | Cytogenetic analysis | - | - | - | - | [1] 285 285 💬 |
1484 | Cytokine-treated Veto Cells | - | - | - | - | [1] 60 60 💬 |
1485 | Cytolytic CD4+ T cells | - | - | - | - | [1] 13 13 💬 |
1486 | Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant | - | - | - | - | [1] 62 62 💬 |
1487 | Cytotoxic Combination | - | - | - | - | [1] 56 56 💬 |
1488 | Cytoxan | - | - | - | - | [1] 60 60 💬 |
1489 | CZP | - | - | - | - | [1] 46 46 💬 |
1490 | Cápsulas de Laquinimod 0.6 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 💬 |
1491 | Células madre mesenquimales | - | - | - | - | [1] 13 13 💬 |
1492 | Células madre mesenquimales de tejido adiposo autólogo | - | - | - | - | [1] 2 2 💬 |
1493 | Células madre mesenquimales haploidénticas derivadas de médula ósea | - | - | - | - | [1] 36 36 💬 |
1494 | Células Mesenquimales de tejido adiposo | - | - | - | - | [1] 2 2 💬 |
1495 | Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas | - | - | - | - | [1] 274 274 💬 |
1496 | Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada PEI nº 12-088) | - | - | - | - | [1] 274 274 💬 |
1497 | Células mesenquimales troncales adultas autólogas de medula ósea expandidas | - | - | - | - | [1] 117 117 💬 |
1498 | Células mesenquimales troncales adultas autólogas de médula ósea expandidas | - | - | - | - | [1] 117 117 💬 |
1499 | Células troncales hematopoyéticas autólogas adultas extraidas de médula ósea | - | - | - | - | [1] 2 2 💬 |